| Code | Display | Comments |
|---|
 100002-5 | Specimen care is maintained | |
| 100003-3 | Team communication is maintained throughout care | |
| 100004-1 | Demonstrates knowledge of the expected psychosocial responses to the procedure | |
| 100005-8 | Demonstrates knowledge of nutritional management related to the procedure | |
| 100006-6 | Demonstrates knowledge of medication management | |
| 100007-4 | Demonstrates knowledge of pain management | |
| 100008-2 | Demonstrates knowledge of wound management | |
| 100009-0 | Demonstrates knowledge of the procedure and expected results | |
| 100010-8 | No injury related to procedure equipment, medical supplies, or instrumentation | |
| 100011-6 | No injury related to an electrical source | |
| 100012-4 | Participates in decisions affecting the patient's plan of care | |
| 100013-2 | Participates in the discharge process | |
| 100014-0 | Psychosocial health is maintained at or improved from baseline | |
| 100015-7 | No injury related to positioning due to care or procedure | |
| 100016-5 | No injury related to a laser source | |
| 100017-3 | Perioperative nursing data set outcomes panel [PNDS] | |
| 100030-6 | Axis I: Temporal aspects score [Mainz Pain Staging System] | |
| 100031-4 | Axis II: Spatial aspects score [Mainz Pain Staging System] | |
| 100032-2 | Axis III: Drug taking behavior score [Mainz Pain Staging System] | |
| 100033-0 | Axis IV: Utilization of the health care system score [Mainz Pain Staging System] | |
| 28079-2 | Activities of daily living alteration [CCC] | | |
| 28080-0 | Activity alteration [CCC] | | |
| 28081-8 | Activity intolerance [CCC] | | |
| 28082-6 | Activity intolerance risk [CCC] | | |
| 28083-4 | Acute pain [CCC] | | |
| 28084-2 | Adjustment impairment [CCC] | | |
| 28085-9 | Airway clearance impairment [CCC] | | |
| 28086-7 | Decisional conflict [CCC] | | |
| 28087-5 | Defensive coping [CCC] | | |
| 28088-3 | Denial [CCC] | | |
| 28089-1 | Diarrhea [CCC] | | |
| 28090-9 | Disabled family coping Family [CCC] | | |
| 28091-7 | Disuse syndrome [CCC] | | |
| 28092-5 | Diversional activity deficit [CCC] | | |
| 28093-3 | Dressing/grooming deficit [CCC] | | |
| 28094-1 | Dying process [CCC] | | |
| 28095-8 | Dysfunctional grieving [CCC] | | |
| 28096-6 | Autonomic dysreflexia [CCC] | | |
| 28097-4 | Endocrine alteration [CCC] | | |
| 28098-2 | Family coping impairment Family [CCC] | | |
| 28099-0 | Family process alteration Family [CCC] | | |
| 28100-6 | Fatigue [CCC] | | |
| 28101-4 | Fear [CCC] | | |
| 28102-2 | Fecal impaction [CCC] | | |
| 28103-0 | Feeding deficit [CCC] | | |
| 28104-8 | Fluid volume alteration [CCC] | | |
| 28105-5 | Fluid volume deficit [CCC] | | |
| 28106-3 | Fluid volume deficit risk [CCC] | | |
| 28107-1 | Fluid volume excess [CCC] | | |
| 28108-9 | Fluid volume excess risk [CCC] | | |
| 28109-7 | Functional urinary incontinence [CCC] | | |
| 28110-5 | Gas exchange impairment [CCC] | | |
| 28111-3 | Gastrointestinal alteration [CCC] | | |
| 28112-1 | Grieving [CCC] | | |
| 28113-9 | Growth and development alteration [CCC] | | |
| 28114-7 | Gustatory alteration [CCC] | | |
| 28115-4 | Health maintenance alteration [CCC] | | |
| 28116-2 | Health-seeking behavior alteration [CCC] | | |
| 28117-0 | Home maintenance alteration [CCC] | | |
| 28118-8 | Hopelessness [CCC] | | |
| 28119-6 | Hypothermia [CCC] | | |
| 28120-4 | Hyperthermia [CCC] | | |
| 28121-2 | Immunologic alteration [CCC] | | |
| 28122-0 | Individual coping impairment [CCC] | | |
| 28123-8 | Infection risk [CCC] | | |
| 28124-6 | Infection [CCC] | | |
| 28125-3 | Injury risk [CCC] | | |
| 28126-1 | Instrumental activity of daily living (IADLS) alteration [CCC] | | |
| 28127-9 | Kinesthetic alteration [CCC] | | |
| 28128-7 | Knowledge deficit [CCC] | | |
| 28129-5 | Knowledge deficit of diagnostic test [CCC] | | |
| 28130-3 | Knowledge deficit of dietary regimen [CCC] | | |
| 28131-1 | Knowledge deficit of disease process [CCC] | | |
| 28132-9 | Knowledge deficit of fluid volume [CCC] | | |
| 28133-7 | Knowledge deficit of medication regimen [CCC] | | |
| 28134-5 | Anticipatory grieving [CCC] | | |
| 28135-2 | Anxiety [CCC] | | |
| 28136-0 | Aspiration risk [CCC] | | |
| 28137-8 | Auditory alteration [CCC] | | |
| 28138-6 | Bathing/hygiene deficit [CCC] | | |
| 28139-4 | Blood pressure alteration [CCC] | | |
| 28140-2 | Body image disturbance [CCC] | | |
| 28141-0 | Body nutrition deficit [CCC] | | |
| 28142-8 | Body nutrition deficit risk [CCC] | | |
| 28143-6 | Body nutrition excess [CCC] | | |
| 28144-4 | Body nutrition excess risk [CCC] | | |
| 28145-1 | Bowel elimination alteration [CCC] | | |
| 28146-9 | Bowel incontinence [CCC] | | |
| 28147-7 | Breastfeeding impairment [CCC] | | |
| 28148-5 | Breathing pattern impairment [CCC] | | |
| 28149-3 | Cardiac output alteration [CCC] | | |
| 28150-1 | Cardiovascular alteration [CCC] | | |
| 28151-9 | Cerebral alteration [CCC] | | |
| 28152-7 | Chronic low self-esteem disturbance [CCC] | | |
| 28153-5 | Chronic pain [CCC] | | |
| 28154-3 | Colonic constipation [CCC] | | |
| 28155-0 | Comfort alteration [CCC] | | |
| 28156-8 | Communication impairment [CCC] | | |
| 28157-6 | Compromised family coping Family [CCC] | | |
| 28158-4 | May choose to self-deliver at the end [Living with HIV] | | |
| 28159-2 | Meaningful life [Living with HIV] | | |
| 28160-0 | Medications are taking over my life [Living with HIV] | | |
| 28161-8 | Need help letting go [Living with HIV] | | |
| 28162-6 | No energy to fight back [Living with HIV] | | |
| 28163-4 | Not enjoying life [Living with HIV] | | |
| 28164-2 | Pain is hard to manage [Living with HIV] | | |
| 28165-9 | So many things yet undone [Living with HIV] | | |
| 28166-7 | Somewhat disconnected [Living with HIV] | | |
| 28167-5 | Stay at home and receive treatment [Living with HIV] | | |
| 28168-3 | Take time for important things [Living with HIV] | | |
| 28169-1 | Use time wisely [Living with HIV] | | |
| 28170-9 | Want to die at home [Living with HIV] | | |
| 28171-7 | Knowledge deficit of safety precautions [CCC] | | |
| 28172-5 | Knowledge deficit of therapeutic regimen [CCC] | | |
| 28173-3 | Meaningfulness alteration [CCC] | | |
| 28174-1 | Medication risk [CCC] | | |
| 28175-8 | Musculoskeletal alteration [CCC] | | |
| 28176-6 | Noncompliance [CCC] | | |
| 28177-4 | Noncompliance with diagnostic test [CCC] | | |
| 28178-2 | Noncompliance with dietary regimen [CCC] | | |
| 28179-0 | Noncompliance with safety precautions [CCC] | | |
| 28180-8 | Noncompliance with therapeutic regimen [CCC] | | |
| 28181-6 | Nutrition alteration [CCC] | | |
| 28182-4 | Olfactory alteration [CCC] | | |
| 28183-2 | Oral mucous membranes impairment [CCC] | | |
| 28184-0 | Parental role conflict [CCC] | | |
| 28185-7 | Parenting alteration [CCC] | | |
| 28186-5 | Perceived constipation [CCC] | | |
| 28187-3 | Peripheral alteration [CCC] | | |
| 28188-1 | Personal identity disturbance [CCC] | | |
| 28189-9 | Physical mobility impairment [CCC] | | |
| 28190-7 | Physical regulation alteration [CCC] | | |
| 28191-5 | Poisoning risk [CCC] | | |
| 28192-3 | Polypharmacy [CCC] | | |
| 28193-1 | Post-trauma response [CCC] | | |
| 28194-9 | Powerlessness [CCC] | | |
| 28195-6 | Protection alteration [CCC] | | |
| 28196-4 | Rape trauma syndrome [CCC] | | |
| 28197-2 | Reflex urinary incontinence [CCC] | | |
| 28198-0 | Renal alteration [CCC] | | |
| 28199-8 | Respiration alteration [CCC] | | |
| 28200-4 | Role performance alteration [CCC] | | |
| 28201-2 | Self-care deficit [CCC] | | |
| 28202-0 | Self-concept alteration [CCC] | | |
| 28203-8 | Sensory perceptual alteration [CCC] | | |
| 28204-6 | Sexual dysfunction [CCC] | | |
| 28205-3 | Sexuality patterns alteration [CCC] | | |
| 28206-1 | Situational self-esteem disturbance [CCC] | | |
| 28207-9 | Skin incision [CCC] | | |
| 28208-7 | Skin integrity impairment [CCC] | | |
| 28209-5 | Skin integrity impairment risk [CCC] | | |
| 28210-3 | Sleep pattern disturbance [CCC] | | |
| 28211-1 | Social interaction alteration [CCC] | | |
| 28212-9 | Social isolation [CCC] | | |
| 28213-7 | Spiritual distress [CCC] | | |
| 28214-5 | Spiritual state alteration [CCC] | | |
| 28215-2 | Stress urinary incontinence [CCC] | | |
| 28216-0 | Suffocation risk [CCC] | | |
| 28217-8 | Sanitation Behavior Family [OMAHA] | | |
| 28218-6 | Sanitation Knowledge Family [OMAHA] | | |
| 28219-4 | Sanitation Status Family [OMAHA] | | |
| 28220-2 | Residence Behavior Family [OMAHA] | | |
| 28221-0 | Residence Knowledge Family [OMAHA] | | |
| 28222-8 | Residence Status Family [OMAHA] | | |
| 28223-6 | Neighborhood/workplace safety.behavior Family [OMAHA] | | |
| 28224-4 | Neighborhood/workplace safety..knowledge Family [OMAHA] | | |
| 28225-1 | Neighborhood/workplace safety.status Family [OMAHA] | | |
| 28226-9 | Swallowing impairment [CCC] | | |
| 28227-7 | Tactile alteration [CCC] | | |
| 28228-5 | Thermoregulation impairment [CCC] | | |
| 28229-3 | Thought process alteration [CCC] | | |
| 28230-1 | Tissue perfusion alteration [CCC] | | |
| 28231-9 | Toileting deficit [CCC] | | |
| 28232-7 | Total urinary incontinence [CCC] | | |
| 28233-5 | Trauma risk [CCC] | | |
| 28234-3 | Unilateral neglect [CCC] | | |
| 28235-0 | Constipation [CCC] | | |
| 28236-8 | Pain [CCC] | | |
| 28237-6 | Urge urinary incontinence [CCC] | | |
| 28238-4 | Urinary elimination alteration [CCC] | | |
| 28239-2 | Urinary retention [CCC] | | |
| 28240-0 | Verbal impairment [CCC] | | |
| 28241-8 | Violence risk [CCC] | | |
| 28242-6 | Visual alteration [CCC] | | |
| 28243-4 | Abuse Behavior [OMAHA] | | |
| 28244-2 | Abuse Knowledge [OMAHA] | | |
| 28245-9 | Abuse Status [OMAHA] | | |
| 28246-7 | Antepartum/postpartum.behavior [OMAHA] | | |
| 28247-5 | Antepartum/postpartum.status [OMAHA] | | |
| 28248-3 | Bowel Function Behavior [OMAHA] | | |
| 28249-1 | Bowel Function Knowledge [OMAHA] | | |
| 28250-9 | Bowel Function Status [OMAHA] | | |
| 28251-7 | Caretaking/parenting.behavior [OMAHA] | | |
| 28252-5 | Caretaking/parenting.knowledge [OMAHA] | | |
| 28253-3 | Caretaking/parenting.status [OMAHA] | | |
| 28254-1 | Circulation Behavior [OMAHA] | | |
| 28255-8 | Circulation Knowledge [OMAHA] | | |
| 28256-6 | Circulation Status [OMAHA] | | |
| 28257-4 | Cognition Behavior [OMAHA] | | |
| 28258-2 | Cognition Knowledge [OMAHA] | | |
| 28259-0 | Cognition Status [OMAHA] | | |
| 28260-8 | Communication With Community Resources Behavior [OMAHA] | | |
| 28261-6 | Communication With Community Resources Knowledge [OMAHA] | | |
| 28262-4 | Communication With Community Resources Status [OMAHA] | | |
| 28263-2 | Consciousness Behavior [OMAHA] | | |
| 28264-0 | Consciousness Knowledge [OMAHA] | | |
| 28265-7 | Consciousness Status [OMAHA] | | |
| 28266-5 | Dentition.behavior [OMAHA] | | |
| 28267-3 | Dentition.knowledge [OMAHA] | | |
| 28268-1 | Dentition.status [OMAHA] | | |
| 28269-9 | Digestion-hydration Behavior [OMAHA] | | |
| 28270-7 | Digestion-hydration Knowledge [OMAHA] | | |
| 28271-5 | Digestion-hydration Status [OMAHA] | | |
| 28272-3 | Mental Health Behavior [OMAHA] | | |
| 28273-1 | Mental Health Knowledge [OMAHA] | | |
| 28274-9 | Mental Health Status [OMAHA] | | |
| 28275-6 | Family Planning Behavior [OMAHA] | | |
| 28276-4 | Family Planning Knowledge [OMAHA] | | |
| 28277-2 | Family Planning Status [OMAHA] | | |
| 28278-0 | Genito-urinary function.behavior [OMAHA] | | |
| 28279-8 | Genito-urinary function.knowledge [OMAHA] | | |
| 28280-6 | Genito-urinary function.status [OMAHA] | | |
| 28281-4 | Grief Behavior [OMAHA] | | |
| 28282-2 | Grief Knowledge [OMAHA] | | |
| 28283-0 | Grief Status [OMAHA] | | |
| 28284-8 | Growth And Development Behavior [OMAHA] | | |
| 28285-5 | Growth And Development Knowledge [OMAHA] | | |
| 28286-3 | Growth And Development Status [OMAHA] | | |
| 28287-1 | Health Care Supervision Behavior [OMAHA] | | |
| 28288-9 | Health Care Supervision Knowledge [OMAHA] | | |
| 28289-7 | Health Care Supervision Status [OMAHA] | | |
| 28290-5 | Hearing Behavior [OMAHA] | | |
| 28291-3 | Hearing Knowledge [OMAHA] | | |
| 28292-1 | Hearing Status [OMAHA] | | |
| 28293-9 | Sexuality Behavior [OMAHA] | | |
| 28294-7 | Sexuality Knowledge [OMAHA] | | |
| 28295-4 | Sexuality Status [OMAHA] | | |
| 28296-2 | Income Behavior [OMAHA] | | |
| 28297-0 | Income Knowledge [OMAHA] | | |
| 28298-8 | Income Status [OMAHA] | | |
| 28299-6 | Skin Behavior [OMAHA] | | |
| 28300-2 | Skin Knowledge [OMAHA] | | |
| 28301-0 | Skin Status [OMAHA] | | |
| 28302-8 | Interpersonal Relationship Behavior [OMAHA] | | |
| 28303-6 | Interpersonal Relationship Knowledge [OMAHA] | | |
| 28304-4 | Interpersonal Relationship Status [OMAHA] | | |
| 28305-1 | Neglect Behavior [OMAHA] | | |
| 28306-9 | Neglect Knowledge [OMAHA] | | |
| 28307-7 | Neglect Status [OMAHA] | | |
| 28308-5 | Neighborhood/workplace safety.behavior [OMAHA] | | |
| 28309-3 | Neighborhood/workplace safety..knowledge [OMAHA] | | |
| 28310-1 | Neighborhood/workplace safety.status [OMAHA] | | |
| 28311-9 | Neuro-musculo-skeletal Function Behavior [OMAHA] | | |
| 28312-7 | Neuro-musculo-skeletal Function Knowledge [OMAHA] | | |
| 28313-5 | Neuro-musculo-skeletal Function Status [OMAHA] | | |
| 28314-3 | Nutrition Behavior [OMAHA] | | |
| 28315-0 | Nutrition Knowledge [OMAHA] | | |
| 28316-8 | Nutrition Status [OMAHA] | | |
| 28317-6 | Pain Behavior [OMAHA] | | |
| 28318-4 | Pain Knowledge [OMAHA] | | |
| 28319-2 | Pain Status [OMAHA] | | |
| 28320-0 | Personal Care Behavior [OMAHA] | | |
| 28321-8 | Personal Care Knowledge [OMAHA] | | |
| 28322-6 | Personal Care Status [OMAHA] | | |
| 28323-4 | Physical Activity Behavior [OMAHA] | | |
| 28324-2 | Physical Activity Knowledge [OMAHA] | | |
| 28325-9 | Physical Activity Status [OMAHA] | | |
| 28326-7 | Medication Regimen Behavior [OMAHA] | | |
| 28327-5 | Medication Regimen Knowledge [OMAHA] | | |
| 28328-3 | Medication Regimen Status [OMAHA] | | |
| 28329-1 | Residence Behavior [OMAHA] | | |
| 28330-9 | Residence Knowledge [OMAHA] | | |
| 28331-7 | Residence Status [OMAHA] | | |
| 28332-5 | Respiration Behavior [OMAHA] | | |
| 28333-3 | Respiration Knowledge [OMAHA] | | |
| 28334-1 | Respiration Status [OMAHA] | | |
| 28335-8 | Role Change Behavior [OMAHA] | | |
| 28336-6 | Role Change Knowledge [OMAHA] | | |
| 28337-4 | Role Change Status [OMAHA] | | |
| 28338-2 | Sanitation Behavior [OMAHA] | | |
| 28339-0 | Sanitation Knowledge [OMAHA] | | |
| 28340-8 | Sanitation Status [OMAHA] | | |
| 28341-6 | Sleep And Rest Pattern Behavior [OMAHA] | | |
| 28342-4 | Sleep And Rest Pattern Knowledge [OMAHA] | | |
| 28343-2 | Sleep And Rest Pattern Status [OMAHA] | | |
| 28344-0 | Social Contact Behavior [OMAHA] | | |
| 28345-7 | Social Contact Knowledge [OMAHA] | | |
| 28346-5 | Social Contact Status [OMAHA] | | |
| 28347-3 | Speech And Language Behavior [OMAHA] | | |
| 28348-1 | Speech And Language Knowledge [OMAHA] | | |
| 28349-9 | Speech And Language Status [OMAHA] | | |
| 28350-7 | Spirituality Behavior [OMAHA] | | |
| 28351-5 | Spirituality Knowledge [OMAHA] | | |
| 28352-3 | Spirituality Status [OMAHA] | | |
| 28353-1 | Substance Use Behavior [OMAHA] | | |
| 28354-9 | Substance Use Knowledge [OMAHA] | | |
| 28355-6 | Substance Use Status [OMAHA] | | |
| 28356-4 | Technical procedure.behavior [OMAHA] | | |
| 28357-2 | Technical procedure.knowledge [OMAHA] | | |
| 28358-0 | Technical procedure.status [OMAHA] | | |
| 28359-8 | Vision Behavior [OMAHA] | | |
| 28360-6 | Vision Knowledge [OMAHA] | | |
| 28361-4 | Vision Status [OMAHA] | | |
| 28362-2 | Anxiety [QAM] | | |
| 28363-0 | Fear [QAM] | | |
| 28364-8 | Afraid of pain and suffering [Living with HIV] | | |
| 28365-5 | Afraid to die [Living with HIV] | | |
| 28366-3 | Comfortable and well cared for [Living with HIV] | | |
| 28367-1 | Don't want high technology to keep me alive [Living with HIV] | | |
| 28368-9 | Don't have to keep fighting [Living with HIV] | | |
| 28369-7 | Embarrassed by the way I look [Living with HIV] | | |
| 28370-5 | Extra effort to do things [Living with HIV] | | |
| 28371-3 | Feel spiritual as I near the end [Living with HIV] | | |
| 28372-1 | Financial situation is distressing [Living with HIV] | | |
| 28373-9 | Frightened over little control [Living with HIV] | | |
| 28374-7 | Giving up things [Living with HIV] | | |
| 28375-4 | Anxiety [HIV-SSC] | | |
| 28376-2 | Chills [HIV-SSC] | | |
| 28377-0 | Day sweats [HIV-SSC] | | |
| 28378-8 | Depression [HIV-SSC] | | |
| 28379-6 | Diarrhea [HIV-SSC] | | |
| 28380-4 | Difficulty concentrating [HIV-SSC] | | |
| 28381-2 | Disorientation [HIV-SSC] | | |
| 28382-0 | Dry mouth [HIV-SSC] | | |
| 28383-8 | Fatigue [HIV-SSC] | | |
| 28384-6 | Fear [HIV-SSC] | | |
| 28385-3 | Fever [HIV-SSC] | | |
| 28386-1 | Gas /bloating [HIV-SSC] | | |
| 28387-9 | Lack of appetite [HIV-SSC] | | |
| 28388-7 | Loose stools [HIV-SSC] | | |
| 28389-5 | Memory loss [HIV-SSC] | | |
| 28390-3 | Muscle aches [HIV-SSC] | | |
| 28391-1 | Nausea [HIV-SSC] | | |
| 28392-9 | Night sweats [HIV-SSC] | | |
| 28393-7 | Painful joints [HIV-SSC] | | |
| 28394-5 | Shortness of breath at rest [HIV-SSC] | | |
| 28395-2 | Shortness of breath with activity [HIV-SSC] | | |
| 28396-0 | Thirsty [HIV-SSC] | | |
| 28397-8 | Vomiting [HIV-SSC] | | |
| 28398-6 | Weakness [HIV-SSC] | | |
| 28399-4 | Wheezing [HIV-SSC] | | |
| 28400-0 | I live for today [Living with HIV] | | |
| 28401-8 | Important to be in charge [Living with HIV] | | |
| 28402-6 | Important to be surrounded by those I love [Living with HIV] | | |
| 28403-4 | Independence [Living with HIV] | | |
| 28404-2 | Live life day to day [Living with HIV] | | |
| 28405-9 | Losing my looks is devastating [Living with HIV] | | |
| 28406-7 | Loss of independence [Living with HIV] | | |
| 28407-5 | Lots of regrets [Living with HIV] | | |
| 28408-3 | Toileting [QAM] | | |
| 28409-1 | Dressing [QAM] | | |
| 28410-9 | Grooming [QAM] | | |
| 28411-7 | Personal hygiene [QAM] | | |
| 28412-5 | Physical performance [QAM] | | |
| 28413-3 | Ambulation [QAM] | | |
| 28414-1 | Activity [QAM] | | |
| 28415-8 | Communication With Community Resources Behavior Family [OMAHA] | | |
| 28416-6 | Communication With Community Resources Knowledge Family [OMAHA] | | |
| 28417-4 | Communication With Community Resources Status Family [OMAHA] | | |
| 28418-2 | Social Contact Behavior Family [OMAHA] | | |
| 28419-0 | Social Contact Knowledge Family [OMAHA] | | |
| 28420-8 | Social Contact Status Family [OMAHA] | | |
| 28421-6 | Role Change Behavior Family [OMAHA] | | |
| 28422-4 | Role Change Knowledge Family [OMAHA] | | |
| 28423-2 | Role Change Status Family [OMAHA] | | |
| 28424-0 | Interpersonal Relationship Knowledge Family [OMAHA] | | |
| 28425-7 | Interpersonal Relationship Status Family [OMAHA] | | |
| 28426-5 | Neglect Behavior Family [OMAHA] | | |
| 28427-3 | Spirituality Behavior Family [OMAHA] | | |
| 28428-1 | Spirituality Knowledge Family [OMAHA] | | |
| 28429-9 | Spirituality Status Family [OMAHA] | | |
| 28430-7 | Grief Behavior Family [OMAHA] | | |
| 28431-5 | Grief Knowledge Family [OMAHA] | | |
| 28432-3 | Grief Status Family [OMAHA] | | |
| 28433-1 | Mental Health Behavior Family [OMAHA] | | |
| 28434-9 | Mental Health Knowledge Family [OMAHA] | | |
| 28435-6 | Mental Health Status Family [OMAHA] | | |
| 28436-4 | Sexuality Behavior Family [OMAHA] | | |
| 28437-2 | Sexuality Knowledge Family [OMAHA] | | |
| 28438-0 | Sexuality Status Family [OMAHA] | | |
| 28439-8 | Interpersonal Relationship Behavior Family [OMAHA] | | |
| 28440-6 | Caretaking/parenting.behavior Family [OMAHA] | | |
| 28441-4 | Caretaking/parenting.knowledge Family [OMAHA] | | |
| 28442-2 | Caretaking/parenting.status Family [OMAHA] | | |
| 28443-0 | Neglect Knowledge Family [OMAHA] | | |
| 28444-8 | Neglect Status Family [OMAHA] | | |
| 28445-5 | Abuse Behavior Family [OMAHA] | | |
| 28446-3 | Abuse Knowledge Family [OMAHA] | | |
| 28447-1 | Abuse Status Family [OMAHA] | | |
| 28448-9 | Growth And Development Behavior Family [OMAHA] | | |
| 28449-7 | Growth And Development Knowledge Family [OMAHA] | | |
| 28450-5 | Growth And Development Status Family [OMAHA] | | |
| 28451-3 | Hearing Behavior Family [OMAHA] | | |
| 28452-1 | Hearing Status Family [OMAHA] | | |
| 28453-9 | Vision Behavior Family [OMAHA] | | |
| 28454-7 | Vision Knowledge Family [OMAHA] | | |
| 28455-4 | Vision Status Family [OMAHA] | | |
| 28456-2 | Speech And Language Behavior Family [OMAHA] | | |
| 28457-0 | Speech And Language Knowledge Family [OMAHA] | | |
| 28458-8 | Speech And Language Status Family [OMAHA] | | |
| 28459-6 | Dentition.behavior Family [OMAHA] | | |
| 28460-4 | Dentition.knowledge Family [OMAHA] | | |
| 28461-2 | Dentition.status Family [OMAHA] | | |
| 28462-0 | Cognition Behavior Family [OMAHA] | | |
| 28463-8 | Cognition Knowledge Family [OMAHA] | | |
| 28464-6 | Cognition Status Family [OMAHA] | | |
| 28465-3 | Pain Behavior Family [OMAHA] | | |
| 28466-1 | Pain Knowledge Family [OMAHA] | | |
| 28467-9 | Pain Status Family [OMAHA] | | |
| 28468-7 | Consciousness Behavior Family [OMAHA] | | |
| 28469-5 | Consciousness Knowledge Family [OMAHA] | | |
| 28470-3 | Consciousness Status Family [OMAHA] | | |
| 28471-1 | Skin Behavior Family [OMAHA] | | |
| 28472-9 | Skin Knowledge Family [OMAHA] | | |
| 28473-7 | Skin Status Family [OMAHA] | | |
| 28474-5 | Neuro-musculo-skeletal Function Behavior Family [OMAHA] | | |
| 28475-2 | Neuro-musculo-skeletal Function Knowledge Family [OMAHA] | | |
| 28476-0 | Neuro-musculo-skeletal Function Status Family [OMAHA] | | |
| 28477-8 | Respiration Behavior Family [OMAHA] | | |
| 28478-6 | Respiration Knowledge Family [OMAHA] | | |
| 28479-4 | Respiration Status Family [OMAHA] | | |
| 28480-2 | Circulation Behavior Family [OMAHA] | | |
| 28481-0 | Circulation Knowledge Family [OMAHA] | | |
| 28482-8 | Circulation Status Family [OMAHA] | | |
| 28483-6 | Digestion-hydration Behavior Family [OMAHA] | | |
| 28484-4 | Digestion-hydration Knowledge Family [OMAHA] | | |
| 28485-1 | Digestion-hydration Status Family [OMAHA] | | |
| 28486-9 | Bowel Function Behavior Family [OMAHA] | | |
| 28487-7 | Bowel Function Knowledge Family [OMAHA] | | |
| 28488-5 | Bowel Function Status Family [OMAHA] | | |
| 28489-3 | Genito-urinary function.behavior Family [OMAHA] | | |
| 28490-1 | Genito-urinary function.knowledge Family [OMAHA] | | |
| 28491-9 | Genito-urinary function.status Family [OMAHA] | | |
| 28492-7 | Antepartum/postpartum.behavior Family [OMAHA] | | |
| 28493-5 | Antepartum/postpartum.status Family [OMAHA] | | |
| 28494-3 | Antepartum/postpartum.knowledge Family [OMAHA] | | |
| 28495-0 | Nutrition Behavior Family [OMAHA] | | |
| 28496-8 | Nutrition Knowledge Family [OMAHA] | | |
| 28497-6 | Nutrition Status Family [OMAHA] | | |
| 28498-4 | Sleep And Rest Pattern Behavior Family [OMAHA] | | |
| 28499-2 | Sleep And Rest Pattern Knowledge Family [OMAHA] | | |
| 28500-7 | Sleep And Rest Pattern Status Family [OMAHA] | | |
| 28501-5 | Physical Activity Behavior Family [OMAHA] | | |
| 28502-3 | Physical Activity Knowledge Family [OMAHA] | | |
| 28503-1 | Physical Activity Status Family [OMAHA] | | |
| 28504-9 | Personal Care Behavior Family [OMAHA] | | |
| 28505-6 | Personal Care Knowledge Family [OMAHA] | | |
| 28506-4 | Personal Care Status Family [OMAHA] | | |
| 28507-2 | Substance Use Behavior Family [OMAHA] | | |
| 28508-0 | Substance Use Knowledge Family [OMAHA] | | |
| 28509-8 | Substance Use Status Family [OMAHA] | | |
| 28510-6 | Family Planning Behavior Family [OMAHA] | | |
| 28511-4 | Family Planning Knowledge Family [OMAHA] | | |
| 28512-2 | Family Planning Status Family [OMAHA] | | |
| 28513-0 | Health Care Supervision Behavior Family [OMAHA] | | |
| 28514-8 | Health Care Supervision Knowledge Family [OMAHA] | | |
| 28515-5 | Health Care Supervision Status Family [OMAHA] | | |
| 28516-3 | Medication Regimen Behavior Family [OMAHA] | | |
| 28517-1 | Medication Regimen Knowledge Family [OMAHA] | | |
| 28518-9 | Medication Regimen Status Family [OMAHA] | | |
| 28519-7 | Technical procedure.behavior Family [OMAHA] | | |
| 28520-5 | Technical procedure.knowledge Family [OMAHA] | | |
| 28521-3 | Technical procedure.status Family [OMAHA] | | |
| 28522-1 | Income Status Family [OMAHA] | | |
| 28523-9 | Noncompliance with fluid volume [CCC] | | |
| 28524-7 | Noncompliance with medication regimen [CCC] | | |
| 28525-4 | Socialization alteration [CCC] | | |
| 28526-2 | Skin integrity alteration [CCC] | | |
| 28527-0 | Family embarrassed [Living with HIV] | | |
| 28528-8 | No good church experience [Living with HIV] | | |
| 28529-6 | Strength from family [Living with HIV] | | |
| 28530-4 | Family does what needs done [Living with HIV] | | |
| 28531-2 | My hometown means a lot [Living with HIV] | | |
| 28532-0 | No purpose in life [Living with HIV] | | |
| 28533-8 | Antepartum/postpartum.knowledge [OMAHA] | | |
| 28534-6 | Bathing [QAM] | | |
| 28535-3 | Income Knowledge Family [OMAHA] | | |
| 28536-1 | Income Behavior Family [OMAHA] | | |
| 28537-9 | Hearing Knowledge Family [OMAHA] | | |
| 28538-7 | Abdominal pain [HIV-SSC] | | |
| 42819-3 | Failure to thrive [CCC] | | |
| 42820-1 | Intracranial adaptive capacity impairment [CCC] | | |
| 42821-9 | Caregiver role strain Caregiver [CCC] | | |
| 42822-7 | Relocation stress syndrome [CCC] | | |
| 42823-5 | Suicide risk [CCC] | | |
| 42824-3 | Self mutilation risk [CCC] | | |
| 42825-0 | Perioperative injury risk [CCC] | | |
| 42826-8 | Perioperative positioning injury [CCC] | | |
| 42827-6 | Surgical recovery delay [CCC] | | |
| 42828-4 | Substance abuse [CCC] | | |
| 42829-2 | Tobacco abuse [CCC] | | |
| 42830-0 | Alcohol abuse [CCC] | | |
| 42831-8 | Drug abuse [CCC] | | |
| 42832-6 | Latex allergy response [CCC] | | |
| 42833-4 | Reproductive risk [CCC] | | |
| 42834-2 | Fertility risk [CCC] | | |
| 42835-9 | Infertility risk [CCC] | | |
| 42836-7 | Contraception risk [CCC] | | |
| 42837-5 | Perinatal risk [CCC] | | |
| 42838-3 | Pregnancy risk [CCC] | | |
| 42839-1 | Labor risk [CCC] | | |
| 42840-9 | Delivery risk [CCC] | | |
| 42841-7 | Postpartum risk [CCC] | | |
| 42842-5 | Newborn behavior alteration [CCC] | | |
| 42843-3 | Infant behavior alteration [CCC] | | |
| 42844-1 | Child behavior alteration [CCC] | | |
| 42845-8 | Adolescent behavior alteration [CCC] | | |
| 42846-6 | Adult behavior alteration [CCC] | | |
| 42847-4 | Sleep deprivation [CCC] | | |
| 42848-2 | Nausea [CCC] | | |
| 42849-0 | Confusion [CCC] | | |
| 42850-8 | Memory impairment [CCC] | | |
| 42851-6 | Infant feeding pattern impairment [CCC] | | |
| 42852-4 | Older adult behavior alteration.sixty five years and older [CCC] | | |
| 42853-2 | Ventilatory weaning impairment [CCC] | | |
| 42854-0 | Community coping impairment Community [CCC] | | |
| 44249-1 | PHQ-9 quick depression assessment panel [Reported.PHQ] | | |
| 44250-9 | Little interest or pleasure in doing things in last 2 weeks | | |
| 44251-7 | Poor appetite or overeating in last 2 weeks [Reported.PHQ] | | |
| 44252-5 | Trouble concentrating on things, such as reading the newspaper or watching television in last 2 weeks [Reported.PHQ] | | |
| 44253-3 | Moving or speaking so slowly that other people could have noticed. Or the opposite - being so fidgety or restless that you have been moving around a lot more than usual in last 2 weeks [Reported.PHQ] | | |
| 44254-1 | Feeling tired or having little energy in last 2 weeks [Reported.PHQ] | | |
| 44255-8 | Feeling down, depressed, or hopeless in last 2 weeks | | |
| 44256-6 | Perceived difficulty in last 2 weeks [Reported.PHQ] | | |
| 44257-4 | Deprecated Patient Health Questionnaire 9 item (PHQ-9) [Reported] | | |
| 44258-2 | Feeling bad about yourself - or that you are a failure or have let yourself or your family down in last 2 weeks [Reported.PHQ] | | |
| 44259-0 | Trouble falling or staying asleep, or sleeping too much in last 2 weeks [Reported.PHQ] | | |
| 44260-8 | Thoughts that you would be better off dead, or of hurting yourself in some way in last 2 weeks [Reported.PHQ] | | |
| 44261-6 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | | |
| 44262-4 | Deprecated PHQ-9 interpretation | | |
| 45399-3 | Federal provider number Facility | | |
| 45405-8 | Ability to understand others [Minimum Data Set] | | |
| 45406-6 | Change in communication/hearing [Minimum Data Set] | | |
| 45407-4 | Vision [Minimum Data Set] | | |
| 45408-2 | Primary reason for assessment [Minimum Data Set (MDS) basic] | | |
| 45409-0 | Codes for assessments required for Medicare PPS or the State [Minimum Data Set] | | |
| 45410-8 | Admitted from (at entry) Facility [Minimum Data Set] | | |
| 45411-6 | Lived alone prior to admission [Minimum Data Set] | | |
| 45412-4 | History of prior stay at this nursing home [Minimum Data Set] | | |
| 45413-2 | History of stay in other nursing home [Minimum Data Set] | | |
| 45414-0 | History of stay in other residential facility [Minimum Data Set] | | |
| 45415-7 | History of stay at mental health/psychiatric setting [Minimum Data Set] | | |
| 45416-5 | History of stay in mental retardation and developmental disabilities setting [Minimum Data Set] | | |
| 45417-3 | None of the listed prior residential settings [Minimum Data Set] | | |
| 45418-1 | Deprecated Lifetime occupations [CMS Assessment] | | |
| 45419-9 | Language.other [Minimum Data Set] | | |
| 45420-7 | Mental health history [Minimum Data Set] | | |
| 45421-5 | No mental retardation and developmental disabilities [Minimum Data Set] | | |
| 45422-3 | Down's syndrome [Minimum Data Set] | | |
| 45423-1 | Autism [Minimum Data Set] | | |
| 45424-9 | Epilepsy [Minimum Data Set] | | |
| 45425-6 | Other organic condition related to mental retardation and developmental disabilities [Minimum Data Set] | | |
| 45426-4 | Mental retardation and developmental disabilities with no organic condition [Minimum Data Set] | | |
| 45427-2 | Date background information form completed [Minimum Data Set] | | |
| 45428-0 | Stays up late at night [Minimum Data Set] | | |
| 45429-8 | Naps regularly during day [Minimum Data Set] | | |
| 45430-6 | Goes out 1 or more days a week [Minimum Data Set] | | |
| 45431-4 | Stays busy with hobbies, reading or fixed daily routine [Minimum Data Set] | | |
| 45432-2 | Spends most time alone or watching TV [Minimum Data Set] | | |
| 45433-0 | Moves independently indoors [Minimum Data Set] | | |
| 45434-8 | Use of tobacco products at least daily [Minimum Data Set] | | |
| 45435-5 | None of the listed cycle of daily events [Minimum Data Set] | | |
| 45436-3 | Distinct food preferences [Minimum Data Set] | | |
| 45437-1 | Eats between meals all or most days [Minimum Data Set] | | |
| 45438-9 | Use of alcohol at least weekly [Minimum Data Set] | | |
| 45439-7 | None of the listed eating patterns [Minimum Data Set] | | |
| 45440-5 | In bedclothes much of day [Minimum Data Set] | | |
| 45441-3 | Wakens to toilet all or most nights [Minimum Data Set] | | |
| 45442-1 | Has irregular bowel movement pattern [Minimum Data Set] | | |
| 45443-9 | Showers for bathing [Minimum Data Set] | | |
| 45444-7 | Bathing in PM [Minimum Data Set] | | |
| 45445-4 | None of the listed additional ADL patterns [Minimum Data Set] | | |
| 45446-2 | Daily contact with relatives/close friends [Minimum Data Set] | | |
| 45447-0 | Usually attends church, temple, etc. [Minimum Data Set] | | |
| 45448-8 | Finds strength in faith [Minimum Data Set] | | |
| 45449-6 | Daily animal companion/presence [Minimum Data Set] | | |
| 45450-4 | Involved in group activities [Minimum Data Set] | | |
| 45451-2 | None of the listed involvement patterns [Minimum Data Set] | | |
| 45452-0 | Unknown customary routine - resident/family unable to provide information [Minimum Data Set] | | |
| 45453-8 | Date of last day of MDS observation period [Minimum Data Set] | | |
| 45454-6 | Original or corrected copy of form # [Minimum Data Set] | | |
| 45455-3 | Date of reentry to facility [Minimum Data Set] | | |
| 45456-1 | Medicaid per diem [Minimum Data Set] | | |
| 45457-9 | Medicare per diem [Minimum Data Set] | | |
| 45458-7 | Medicare ancillary part A [Minimum Data Set] | | |
| 45459-5 | Medicare ancillary part B [Minimum Data Set] | | |
| 45460-3 | CHAMPUS Per Diem [Minimum Data Set] | | |
| 45461-1 | VA Per Diem [Minimum Data Set] | | |
| 45462-9 | Self or family pays for full per diem [Minimum Data Set] | | |
| 45463-7 | Medicaid resident liability or Medicare copayment [Minimum Data Set] | | |
| 45464-5 | Private insurance per diem [Minimum Data Set] | | |
| 45465-2 | Other per diem [Minimum Data Set] | | |
| 45466-0 | Legal guardian [Minimum Data Set] | | |
| 45467-8 | Other legal oversight [Minimum Data Set] | | |
| 45468-6 | Health care durable power attorney [Minimum Data Set] | | |
| 45469-4 | Financial durable power attorney [Minimum Data Set] | | |
| 45470-2 | Family member responsible [Minimum Data Set] | | |
| 45471-0 | Patient responsible for self [Minimum Data Set] | | |
| 45472-8 | Responsibility - none of above [Minimum Data Set] | | |
| 45474-4 | Advance directive - do not resuscitate [Minimum Data Set] | | |
| 45475-1 | Advance directive - do not hospitalize [Minimum Data Set] | | |
| 45476-9 | Advance directive - organ donation [Minimum Data Set] | | |
| 45477-7 | Advance directive - autopsy request [Minimum Data Set] | | |
| 45478-5 | Advance directive - feeding restrictions [Minimum Data Set] | | |
| 45479-3 | Advance directive - medication restrictions [Minimum Data Set] | | |
| 45480-1 | Advance directive - other treatment restrictions [Minimum Data Set] | | |
| 45481-9 | Advance directive - none [Minimum Data Set] | | |
| 45482-7 | Comatose [CMS Assessment] | | |
| 45483-5 | Short-term memory OK [Minimum Data Set] | | |
| 45484-3 | Long-term memory OK [Minimum Data Set] | | |
| 45485-0 | Can recall current season [Minimum Data Set] | | |
| 45486-8 | Can recall location of own room [Minimum Data Set] | | |
| 45487-6 | Can recall staff names/faces [Minimum Data Set] | | |
| 45488-4 | Can recall that he or she is in nursing home [Minimum Data Set] | | |
| 45489-2 | Memory/recall - none of above are recalled [Minimum Data Set] | | |
| 45490-0 | Cognitive skills for daily decision making [Minimum Data Set] | | |
| 45491-8 | Easily distracted [Minimum Data Set] | | |
| 45492-6 | Periods of altered perception or awareness of surroundings [Minimum Data Set] | | |
| 45493-4 | Episodes of disorganized speech [Minimum Data Set] | | |
| 45494-2 | Periods of restlessness [Minimum Data Set] | | |
| 45495-9 | Periods of lethargy [Minimum Data Set] | | |
| 45496-7 | Mental function varies over the course of the day [Minimum Data Set] | | |
| 45497-5 | Change in cognitive status [Minimum Data Set] | | |
| 45498-3 | Hearing [Minimum Data Set] | | |
| 45499-1 | Hearing aid present and used [Minimum Data Set] | | |
| 45500-6 | Hearing aid present and not used regularly [Minimum Data Set] | | |
| 45501-4 | Other receptive communication techniques used [Minimum Data Set] | | |
| 45502-2 | No communication device [Minimum Data Set] | | |
| 45503-0 | Uses speech [Minimum Data Set] | | |
| 45504-8 | Uses written messages to express or clarify needs [Minimum Data Set] | | |
| 45505-5 | Uses American sign language or Braille [Minimum Data Set] | | |
| 45506-3 | Uses signs/gestures/sounds [Minimum Data Set] | | |
| 45507-1 | Uses communication board [Minimum Data Set] | | |
| 45508-9 | Uses other modes of expression [Minimum Data Set] | | |
| 45509-7 | Modes of expression - none of above [Minimum Data Set] | | |
| 45510-5 | Making self understood [Minimum Data Set] | | |
| 45511-3 | Speech clarity [Minimum Data Set] | | |
| 45512-1 | Side vision problems [Minimum Data Set] | | |
| 45513-9 | Sees halos or rings around lights, flashes of light, or curtains over eyes [Minimum Data Set] | | |
| 45514-7 | No visual limitations [Minimum Data Set] | | |
| 45515-4 | Visual appliances [Minimum Data Set] | | |
| 45516-2 | Resident made negative statements [Minimum Data Set] | | |
| 45517-0 | Repetitive questions [Minimum Data Set] | | |
| 45518-8 | Repetitive verbalizations [Minimum Data Set] | | |
| 45519-6 | Persistent anger with self or others [Minimum Data Set] | | |
| 45520-4 | Self deprecation [Minimum Data Set] | | |
| 45521-2 | Expression of what appear to be unrealistic fears [Minimum Data Set] | | |
| 45522-0 | Recurrent statements that something terrible is about to happen [Minimum Data Set] | | |
| 45523-8 | Balance while sitting - position, trunk control [Minimum Data Set] | | |
| 45524-6 | Range of motion Neck [Minimum Data Set] | | |
| 45525-3 | Voluntary movement Neck [Minimum Data Set] | | |
| 45526-1 | Range of motion Upper extremity [Minimum Data Set] | | |
| 45527-9 | Voluntary movement Upper extremity [Minimum Data Set] | | |
| 45528-7 | Range of motion Hand [Minimum Data Set] | | |
| 45529-5 | Voluntary movement Hand [Minimum Data Set] | | |
| 45530-3 | Range of motion Lower extremity [Minimum Data Set] | | |
| 45531-1 | Voluntary movement Lower extremity [Minimum Data Set] | | |
| 45532-9 | Range of motion Foot [Minimum Data Set] | | |
| 45533-7 | Voluntary movement Foot [Minimum Data Set] | | |
| 45534-5 | Other limitation or loss - range of motion [Minimum Data Set] | | |
| 45535-2 | Other limitation or loss - voluntary movement [Minimum Data Set] | | |
| 45536-0 | Uses cane, walker or crutch [Minimum Data Set] | | |
| 45537-8 | Wheeled self [Minimum Data Set] | | |
| 45538-6 | Other person wheeled [Minimum Data Set] | | |
| 45539-4 | Wheelchair primary mode of locomotion [Minimum Data Set] | | |
| 45540-2 | No modes of locomotion [Minimum Data Set] | | |
| 45541-0 | Bedfast all or most of the time [Minimum Data Set] | | |
| 45542-8 | Bed rails used for bed mobility or transfer [Minimum Data Set] | | |
| 45543-6 | Lifted manually [Minimum Data Set] | | |
| 45544-4 | Lifted mechanically [Minimum Data Set] | | |
| 45545-1 | Transfer aid [Minimum Data Set] | | |
| 45546-9 | No mode of transfer [Minimum Data Set] | | |
| 45547-7 | Repetitive health complaints [Minimum Data Set] | | |
| 45548-5 | Repetitive anxious complaints or concerns [Minimum Data Set] | | |
| 45549-3 | Unpleasant mood in morning [Minimum Data Set] | | |
| 45550-1 | Insomnia/change in sleeping pattern [Minimum Data Set] | | |
| 45551-9 | Sad, pained, or worried facial expressions [Minimum Data Set] | | |
| 45552-7 | Crying or tearfulness [Minimum Data Set] | | |
| 45553-5 | Repetitive physical movements [Minimum Data Set] | | |
| 45554-3 | Withdrawal from activities of interest [Minimum Data Set] | | |
| 45555-0 | Reduced social interaction [Minimum Data Set] | | |
| 45556-8 | Mood persistence [Minimum Data Set] | | |
| 45557-6 | Change in mood [Minimum Data Set] | | |
| 45558-4 | Frequency of wandering [Minimum Data Set] | | |
| 45559-2 | Alterability of wandering [Minimum Data Set] | | |
| 45560-0 | Frequency of verbally abusive behavioral symptoms [Minimum Data Set] | | |
| 45561-8 | Alterability of verbally abusive behavioral symptoms [Minimum Data Set] | | |
| 45562-6 | Frequency of physically abusive behavioral symptoms [Minimum Data Set] | | |
| 45563-4 | Alterability of physically abusive behavioral symptoms [Minimum Data Set] | | |
| 45564-2 | Frequency of socially inappropriate or disruptive behavioral symptoms [Minimum Data Set] | | |
| 45565-9 | Alterability of socially inappropriate or disruptive behavioral symptoms [Minimum Data Set] | | |
| 45566-7 | Frequency of resists care [Minimum Data Set] | | |
| 45567-5 | Alterability of resists care [Minimum Data Set] | | |
| 45568-3 | Change in behavioral symptoms [Minimum Data Set] | | |
| 45569-1 | At ease interacting with others [Minimum Data Set] | | |
| 45570-9 | At ease doing planned or structured activities [Minimum Data Set] | | |
| 45571-7 | At ease doing self-initiated activities [Minimum Data Set] | | |
| 45572-5 | Establishes own goals [Minimum Data Set] | | |
| 45573-3 | Pursues involvement in life of facility [Minimum Data Set] | | |
| 45574-1 | Accepts invitations to most group activities [Minimum Data Set] | | |
| 45575-8 | Sense of initiative - none of above [Minimum Data Set] | | |
| 45576-6 | Covert/open conflict with or repeated criticism of staff [Minimum Data Set] | | |
| 45577-4 | Unhappy with roommate [Minimum Data Set] | | |
| 45578-2 | Unhappy with residents other than roommate [Minimum Data Set] | | |
| 45579-0 | Openly expresses conflict/anger with family/friends [Minimum Data Set] | | |
| 45580-8 | Absence of contact with family/friends [Minimum Data Set] | | |
| 45581-6 | Recent loss of close family member/friend [Minimum Data Set] | | |
| 45582-4 | Does not adjust easily to change in routines [Minimum Data Set] | | |
| 45583-2 | No unsettled relationships [Minimum Data Set] | | |
| 45584-0 | Strong identification with past roles and life status [Minimum Data Set] | | |
| 45585-7 | Expresses sadness/anger/empty feeling over lost roles/status [Minimum Data Set] | | |
| 45586-5 | Resident perceives that daily routine (customary routine, activities) is very different from prior pattern in the community [Minimum Data Set] | | |
| 45587-3 | Past roles - none of above [Minimum Data Set] | | |
| 45588-1 | Bed mobility - self-performance during assessment period [CMS Assessment] | | |
| 45589-9 | Bed mobility - support provided during assessment period [CMS Assessment] | | |
| 45590-7 | Transfer - self-performance during assessment period [CMS Assessment] | | |
| 45591-5 | Transfer - support provided during assessment period [CMS Assessment] | | |
| 45592-3 | Walk in room - self-performance during assessment period [CMS Assessment] | | |
| 45593-1 | Walk in room - support provided during assessment period [CMS Assessment] | | |
| 45594-9 | Walk in corridor - self-performance during assessment period [CMS Assessment] | | |
| 45595-6 | Walk in corridor - support provided during assessment period [CMS Assessment] | | |
| 45596-4 | Locomotion on unit - self-performance during assessment period [CMS Assessment] | | |
| 45597-2 | Locomotion on unit - support provided during assessment period [CMS Assessment] | | |
| 45598-0 | Locomotion off unit - self-performance during assessment period [CMS Assessment] | | |
| 45599-8 | Locomotion off unit - support provided during assessment period [CMS Assessment] | | |
| 45600-4 | Dressing - self-performance during assessment period [CMS Assessment] | | |
| 45601-2 | Dressing - support provided during assessment period [CMS Assessment] | | |
| 45602-0 | Eating - self-performance during assessment period [CMS Assessment] | | |
| 45603-8 | Eating - support provided during assessment period [CMS Assessment] | | |
| 45604-6 | Toilet use - self-performance during assessment period [CMS Assessment] | | |
| 45605-3 | Toilet use - support provided during assessment period [CMS Assessment] | | |
| 45606-1 | Personal hygiene - self-performance during assessment period [CMS Assessment] | | |
| 45607-9 | Personal hygiene - support provided during assessment period [CMS Assessment] | | |
| 45608-7 | Bathing - self-performance during assessment period [CMS Assessment] | | |
| 45609-5 | Bathing - support provided during assessment period [CMS Assessment] | | |
| 45610-3 | Balance while standing [Minimum Data Set] | | |
| 45611-1 | Task segmentation [Minimum Data Set] | | |
| 45612-9 | Resident believes he or she is capable of increased independence in at least some ADLs [Minimum Data Set] | | |
| 45613-7 | Direct care staff believe resident is capable of increased independence in at least some ADLs [CMS Assessment] | | |
| 45614-5 | Resident able to perform tasks or activity but is very slow [Minimum Data Set] | | |
| 45615-2 | Difference in ADL Self-Performance or ADL Support, comparing mornings to evenings [Minimum Data Set] | | |
| 45616-0 | Activities of daily living rehabilitation potential - none of above [Minimum Data Set] | | |
| 45617-8 | Change in activities of daily living function [Minimum Data Set] | | |
| 45618-6 | Bowel continence [Minimum Data Set] | | |
| 45619-4 | Bladder continence [Minimum Data Set] | | |
| 45620-2 | Bowel elimination pattern regular - at least one movement every three days [Minimum Data Set] | | |
| 45621-0 | Constipation [Minimum Data Set] | | |
| 45622-8 | Diarrhea [Minimum Data Set] | | |
| 45623-6 | Fecal impaction [Minimum Data Set] | | |
| 45624-4 | Bowel elimination pattern - none of above [Minimum Data Set] | | |
| 45625-1 | Any scheduled toileting plan [Minimum Data Set] | | |
| 45626-9 | Bladder retraining program [Minimum Data Set] | | |
| 45627-7 | External catheter [Minimum Data Set] | | |
| 45628-5 | Indwelling catheter [Minimum Data Set] | | |
| 45629-3 | Intermittent catheter [Minimum Data Set] | | |
| 45630-1 | Did not use toilet room/commode/urinal [Minimum Data Set] | | |
| 45631-9 | Pads/briefs used [Minimum Data Set] | | |
| 45632-7 | Enemas/irrigation [Minimum Data Set] | | |
| 45633-5 | Ostomy present [Minimum Data Set] | | |
| 45634-3 | Continence appliances and programs - none of above [Minimum Data Set] | | |
| 45635-0 | Change in urinary continence [Minimum Data Set] | | |
| 45636-8 | Diabetes mellitus [Minimum Data Set] | | |
| 45637-6 | Hyperthyroidism [Minimum Data Set] | | |
| 45638-4 | Hypothyroidism [Minimum Data Set] | | |
| 45639-2 | Arteriosclerotic heart disease [Minimum Data Set] | | |
| 45640-0 | Cardiac dysrhythmias [Minimum Data Set] | | |
| 45641-8 | Congestive heart failure [Minimum Data Set] | | |
| 45642-6 | Deep vein thrombosis [Minimum Data Set] | | |
| 45643-4 | Hypertension [Minimum Data Set] | | |
| 45644-2 | Hypotension [Minimum Data Set] | | |
| 45645-9 | Peripheral vascular disease [Minimum Data Set] | | |
| 45646-7 | Other cardiovascular disease [Minimum Data Set] | | |
| 45647-5 | Arthritis [Minimum Data Set] | | |
| 45648-3 | Hip fracture [Minimum Data Set] | | |
| 45649-1 | Missing limb [Minimum Data Set] | | |
| 45650-9 | Osteoporosis [Minimum Data Set] | | |
| 45651-7 | Pathological bone fracture [Minimum Data Set] | | |
| 45652-5 | Alzheimer's disease [Minimum Data Set] | | |
| 45653-3 | Aphasia [Minimum Data Set] | | |
| 45654-1 | Cerebral palsy [Minimum Data Set] | | |
| 45655-8 | Cerebrovascular accident [Minimum Data Set] | | |
| 45656-6 | Dementia other than Alzheimer's disease [Minimum Data Set] | | |
| 45657-4 | Hemiplegia or hemiparesis [Minimum Data Set] | | |
| 45658-2 | Multiple sclerosis [Minimum Data Set] | | |
| 45659-0 | Paraplegia [Minimum Data Set] | | |
| 45660-8 | Parkinson's disease [Minimum Data Set] | | |
| 45661-6 | Quadriplegia [Minimum Data Set] | | |
| 45662-4 | Seizure disorder [Minimum Data Set] | | |
| 45663-2 | Transient ischemic attack [Minimum Data Set] | | |
| 45664-0 | Traumatic brain injury [Minimum Data Set] | | |
| 45665-7 | Anxiety disorder [Minimum Data Set] | | |
| 45666-5 | Depression [Minimum Data Set] | | |
| 45667-3 | Manic depression [Minimum Data Set] | | |
| 45668-1 | Schizophrenia [Minimum Data Set] | | |
| 45669-9 | Asthma [Minimum Data Set] | | |
| 45670-7 | Emphysema or COPD [Minimum Data Set] | | |
| 45671-5 | Cataracts [Minimum Data Set] | | |
| 45672-3 | Diabetic retinopathy [Minimum Data Set] | | |
| 45673-1 | Glaucoma [Minimum Data Set] | | |
| 45674-9 | Macular degeneration [Minimum Data Set] | | |
| 45676-4 | Anemia [Minimum Data Set] | | |
| 45677-2 | Cancer [Minimum Data Set] | | |
| 45678-0 | Renal failure [Minimum Data Set] | | |
| 45679-8 | None of the listed diseases or conditions [Minimum Data Set] | | |
| 45680-6 | Antibiotic resistant infection [Minimum Data Set] | | |
| 45681-4 | Infection with Clostridioides difficile [Minimum Data Set] | | |
| 45682-2 | Conjunctivitis [Minimum Data Set] | | |
| 45683-0 | HIV infection [Minimum Data Set] | | |
| 45684-8 | Pneumonia [Minimum Data Set] | | |
| 45685-5 | Respiratory infection [Minimum Data Set] | | |
| 45686-3 | Septicemia [Minimum Data Set] | | |
| 45687-1 | Sexually transmitted diseases [Minimum Data Set] | | |
| 45688-9 | Tuberculosis [Minimum Data Set] | | |
| 45689-7 | Urinary tract infection in last 30 days [Minimum Data Set] | | |
| 45690-5 | Viral hepatitis [Minimum Data Set] | | |
| 45691-3 | Wound infection [Minimum Data Set] | | |
| 45692-1 | Infections - none of above [Minimum Data Set] | | |
| 45693-9 | Other current or more detailed diagnoses and ICD9 codes [Minimum Data Set] | | |
| 45694-7 | Weight gain or loss of 3+ Lbs. within a 7 day period [Minimum Data Set] | | |
| 45695-4 | Inability to lie flat due to shortness of breath [Minimum Data Set] | | |
| 45696-2 | Dehydrated [Minimum Data Set] | | |
| 45697-0 | Insufficient fluid; did NOT consume all or almost all liquids provided during last 3 days [Minimum Data Set] | | |
| 45698-8 | Delusions [Minimum Data Set] | | |
| 45699-6 | Dizziness or vertigo [Minimum Data Set] | | |
| 45700-2 | Edema [Minimum Data Set] | | |
| 45701-0 | Fever [Minimum Data Set] | | |
| 45702-8 | Hallucinations [Minimum Data Set] | | |
| 45703-6 | Internal bleeding [Minimum Data Set] | | |
| 45704-4 | Recurrent lung aspirations in last 90 days [Minimum Data Set] | | |
| 45705-1 | Shortness of breath [Minimum Data Set] | | |
| 45706-9 | Syncope [Minimum Data Set] | | |
| 45707-7 | Unsteady gait [Minimum Data Set] | | |
| 45708-5 | Vomiting [Minimum Data Set] | | |
| 45709-3 | Problem conditions - none of above [Minimum Data Set] | | |
| 45710-1 | Pain frequency [Minimum Data Set] | | |
| 45711-9 | Pain intensity [Minimum Data Set] | | |
| 45712-7 | Back pain [Minimum Data Set] | | |
| 45713-5 | Bone pain [Minimum Data Set] | | |
| 45714-3 | Chest pain while doing usual activities [Minimum Data Set] | | |
| 45715-0 | Headache [Minimum Data Set] | | |
| 45716-8 | Hip pain [Minimum Data Set] | | |
| 45717-6 | Incisional pain [Minimum Data Set] | | |
| 45718-4 | Joint pain [Minimum Data Set] | | |
| 45719-2 | Soft tissue pain [Minimum Data Set] | | |
| 45720-0 | Stomach pain [Minimum Data Set] | | |
| 45721-8 | Other pain [Minimum Data Set] | | |
| 45722-6 | Fell in past 30 days [Minimum Data Set] | | |
| 45723-4 | Fell in past 31-180 days [Minimum Data Set] | | |
| 45724-2 | Hip fracture in last 180 days [Minimum Data Set] | | |
| 45725-9 | Other fracture in last 180 days [Minimum Data Set] | | |
| 45726-7 | Accidents - none of above [Minimum Data Set] | | |
| 45727-5 | Conditions/diseases make resident's cognitive, ADL, mood or behavior patterns unstable [Minimum Data Set] | | |
| 45728-3 | Resident experiencing an acute episode or a flare-up of a recurrent or chronic problem [Minimum Data Set] | | |
| 45729-1 | End-Stage disease, 6 or fewer months to live [Minimum Data Set] | | |
| 45730-9 | Stability of conditions - none of above [Minimum Data Set] | | |
| 45731-7 | Chewing problem [Minimum Data Set] | | |
| 45732-5 | Swallowing problem [Minimum Data Set] | | |
| 45733-3 | Mouth pain [Minimum Data Set] | | |
| 45734-1 | Oral problems - none of above [Minimum Data Set] | | |
| 45735-8 | Weight loss [Minimum Data Set] | | |
| 45736-6 | Weight gain [Minimum Data Set] | | |
| 45737-4 | Complains about the taste of many foods [Minimum Data Set] | | |
| 45738-2 | Regular or repetitive complaints of hunger [Minimum Data Set] | | |
| 45739-0 | Leaves 25%+ food uneaten at most meals [Minimum Data Set] | | |
| 45740-8 | Nutritional problems - none of above [Minimum Data Set] | | |
| 45741-6 | Parenteral IV [Minimum Data Set] | | |
| 45742-4 | Feeding tube [Minimum Data Set] | | |
| 45743-2 | Mechanically altered diet [Minimum Data Set] | | |
| 45744-0 | Syringe or oral feeding [Minimum Data Set] | | |
| 45745-7 | Therapeutic diet [Minimum Data Set] | | |
| 45746-5 | Dietary supplement between meals [Minimum Data Set] | | |
| 45747-3 | Plate guard, stabilized built-up utensil, etc. [Minimum Data Set] | | |
| 45748-1 | On a planned weight change program [Minimum Data Set] | | |
| 45749-9 | Nutritional approaches - none of above [Minimum Data Set] | | |
| 45750-7 | Proportion of total calories received through parenteral or tube feeding in last 7 days [Minimum Data Set] | | |
| 45751-5 | Deprecated Average fluid intake per day by IV or tube in last 7 days [Minimum Data Set] | | |
| 45752-3 | Ventilator or respirator [Minimum Data Set] | | |
| 45753-1 | Alcohol or drug treatment program | | |
| 45754-9 | Alzheimer's or dementia special care unit [Minimum Data Set] | | |
| 45755-6 | Hospice care [Minimum Data Set] | | |
| 45756-4 | Pediatric unit [Minimum Data Set] | | |
| 45757-2 | Respite care [Minimum Data Set] | | |
| 45758-0 | Training in skills required to return to the community [Minimum Data Set] | | |
| 45759-8 | Special treatments/programs - none of above [Minimum Data Set] | | |
| 45760-6 | Number of days with at least 15 minutes of speech language pathology and audiology services in the last 7 days [CMS Assessment] | | |
| 45761-4 | Total minutes of speech language pathology and audiology services in the last 7 days [Minimum Data Set] | | |
| 45762-2 | Number of days with at least 15 minutes of occupational therapy in the last 7 days [CMS Assessment] | | |
| 45763-0 | Total minutes of occupational therapy in the last 7 days [Minimum Data Set] | | |
| 45764-8 | Number of days with at least 15 minutes of physical therapy in the last 7 days [CMS Assessment] | | |
| 45765-5 | Total minutes of physical therapy in the last 7 days [Minimum Data Set] | | |
| 45766-3 | Number of days with at least 15 minutes of respiratory therapy in the last 7 days [CMS Assessment] | | |
| 45767-1 | Total minutes of respiratory therapy in the last 7 days [CMS Assessment] | | |
| 45768-9 | Number of days with at least 15 minutes of psychological therapy by any licensed mental health professional in the last 7 days [CMS Assessment] | | |
| 45769-7 | Debris - soft, easily movable substances - present in mouth prior to going to bed at night [Minimum Data Set] | | |
| 45770-5 | Has dentures or removable bridge [Minimum Data Set] | | |
| 45771-3 | Some or all natural teeth lost but does not have or use dentures or partial plates [Minimum Data Set] | | |
| 45772-1 | Broken, loose, or carious teeth [Minimum Data Set] | | |
| 45773-9 | Inflamed, swollen, or bleeding gums, oral abscesses; ulcers or rashes [Minimum Data Set] | | |
| 45774-7 | Daily cleaning of teeth or dentures or mouth care by resident or staff [Minimum Data Set] | | |
| 45775-4 | Oral status/disease prevention - none of above [Minimum Data Set] | | |
| 45776-2 | Ulcers.stage 1 # [Minimum Data Set] | | |
| 45777-0 | Ulcers.stage 2 # [Minimum Data Set] | | |
| 45778-8 | Ulcers.stage 3 # [Minimum Data Set] | | |
| 45779-6 | Ulcers.stage 4 # [Minimum Data Set] | | |
| 45780-4 | Pressure injury stage [Minimum Data Set] | | |
| 45781-2 | Stasis ulcer stage [Minimum Data Set] | | |
| 45782-0 | History of resolved ulcers [Minimum Data Set] | | |
| 45783-8 | Abrasions or bruises [Minimum Data Set] | | |
| 45784-6 | Second or third degree burns [Minimum Data Set] | | |
| 45785-3 | Open lesions other than ulcers, rashes, cuts [Minimum Data Set] | | |
| 45786-1 | Rashes [Minimum Data Set] | | |
| 45787-9 | Skin desensitized to pain or pressure [Minimum Data Set] | | |
| 45788-7 | Skin tears or cuts (other than surgery) [Minimum Data Set] | | |
| 45789-5 | Surgical wounds [Minimum Data Set] | | |
| 45790-3 | Other skin problems - none of above [Minimum Data Set] | | |
| 45791-1 | Pressure relieving devices for chair [Minimum Data Set] | | |
| 45792-9 | Pressure relieving devices for bed [Minimum Data Set] | | |
| 45793-7 | Turning or repositioning program [Minimum Data Set] | | |
| 45794-5 | Nutrition or hydration intervention to manage skin problems [Minimum Data Set] | | |
| 45795-2 | Ulcer care [Minimum Data Set] | | |
| 45796-0 | Surgical wound care [Minimum Data Set] | | |
| 45797-8 | Application of dressings (with or without topical medications) other than to feet [Minimum Data Set] | | |
| 45798-6 | Application of ointments or medications other than to feet [Minimum Data Set] | | |
| 45799-4 | Other preventative or protective skin care other than to feet [Minimum Data Set] | | |
| 45800-0 | Skin treatments - none of above [Minimum Data Set] | | |
| 45801-8 | One or more foot problems [Minimum Data Set] | | |
| 45802-6 | Infection of foot [Minimum Data Set] | | |
| 45803-4 | Open lesions on the foot [Minimum Data Set] | | |
| 45804-2 | Nails/calluses trimmed during last 90 days [Minimum Data Set] | | |
| 45805-9 | Received preventative or protective foot care [Minimum Data Set] | | |
| 45806-7 | Application of dressings (foot) - with or without topical medications [Minimum Data Set] | | |
| 45807-5 | Foot problems and care - none of above [Minimum Data Set] | | |
| 45808-3 | Awake in morning [Minimum Data Set] | | |
| 45809-1 | Awake in afternoon [Minimum Data Set] | | |
| 45810-9 | Awake in evening [Minimum Data Set] | | |
| 45811-7 | Time awake - none of above [Minimum Data Set] | | |
| 45812-5 | Average time involved in activities [Minimum Data Set] | | |
| 45813-3 | Preferred activity setting - own room [Minimum Data Set] | | |
| 45814-1 | Preferred activity setting - day or activity room [Minimum Data Set] | | |
| 45815-8 | Preferred activity setting - inside NH/off unit [Minimum Data Set] | | |
| 45816-6 | Preferred activity setting - outside facility [Minimum Data Set] | | |
| 45817-4 | Preferred activitty setting - none of above [Minimum Data Set] | | |
| 45818-2 | Activity preferences - cards or other games [Minimum Data Set] | | |
| 45819-0 | Activity preferences - crafts or arts [Minimum Data Set] | | |
| 45820-8 | Activity preferences - exercise or sports [Minimum Data Set] | | |
| 45821-6 | Activity preferences - music [Minimum Data Set] | | |
| 45822-4 | Activity preferences - reading or writing [Minimum Data Set] | | |
| 45823-2 | Activity preferences - spiritual or religious activities [Minimum Data Set] | | |
| 45824-0 | Activity preferences - trips or shopping [Minimum Data Set] | | |
| 45825-7 | Activity preferences - walking or wheeling outdoors [Minimum Data Set] | | |
| 45826-5 | Activity preferences - watching TV [Minimum Data Set] | | |
| 45827-3 | Activity preferences - gardening or plants [Minimum Data Set] | | |
| 45828-1 | Activity preferences - talking or conversing [Minimum Data Set] | | |
| 45829-9 | Activity preferences - helping others [Minimum Data Set] | | |
| 45830-7 | Activity preferences - none of above [Minimum Data Set] | | |
| 45831-5 | Type of activities in which resident is currently involved [Minimum Data Set] | | |
| 45832-3 | Extent of resident involvement in activities [Minimum Data Set] | | |
| 45833-1 | Number of medications [Minimum Data Set] | | |
| 45834-9 | New medications [Minimum Data Set] | | |
| 45835-6 | Number of days injections received [Minimum Data Set] | | |
| 45836-4 | Number of days antipsychotic medication received [Minimum Data Set] | | |
| 45837-2 | Number of days antianxiety medication received [Minimum Data Set] | | |
| 45838-0 | Number of days antidepressant medication received [Minimum Data Set] | | |
| 45839-8 | Number of days hypnotic medication received [Minimum Data Set] | | |
| 45840-6 | Number of days diuretic medication received [Minimum Data Set] | | |
| 45841-4 | Chemotherapy [Minimum Data Set] | | |
| 45842-2 | Dialysis [Minimum Data Set] | | |
| 45843-0 | IV medication [Minimum Data Set] | | |
| 45844-8 | Intake/output [Minimum Data Set] | | |
| 45845-5 | Monitoring of acute medical condition [Minimum Data Set] | | |
| 45846-3 | Ostomy care [Minimum Data Set] | | |
| 45847-1 | Oxygen therapy [Minimum Data Set] | | |
| 45848-9 | Radiation [Minimum Data Set] | | |
| 45849-7 | Suctioning [Minimum Data Set] | | |
| 45850-5 | Tracheostomy care [Minimum Data Set] | | |
| 45851-3 | Transfusions [Minimum Data Set] | | |
| 45852-1 | Total minutes of psychological therapy by any licensed mental health professional in the last 7 days [CMS Assessment] | | |
| 45853-9 | Special behavior symptom evaluation program [Minimum Data Set] | | |
| 45854-7 | Evaluation by a licensed mental health specialist in last 90 days [Minimum Data Set] | | |
| 45855-4 | Group therapy [Minimum Data Set] | | |
| 45856-2 | Resident-specific deliberate changes in the environment to address mood/behavior patterns [Minimum Data Set] | | |
| 45857-0 | Reorientation [Minimum Data Set] | | |
| 45858-8 | Mood, behavior, cognitive loss programs - none of above [Minimum Data Set] | | |
| 45859-6 | Number of days of passive range of motion [Minimum Data Set] | | |
| 45860-4 | Number of days of active range of motion [Minimum Data Set] | | |
| 45861-2 | Number of days of splint or brace assistance [Minimum Data Set] | | |
| 45862-0 | Number of days of training and skill practice in bed mobility [Minimum Data Set] | | |
| 45863-8 | Number of days of training and skill practice in transfer [Minimum Data Set] | | |
| 45864-6 | Number of days of training and skill practice in walking [Minimum Data Set] | | |
| 45865-3 | Number of days of training and skill practice in dressing or grooming [Minimum Data Set] | | |
| 45866-1 | Number of days of training and skill practice in eating or swallowing [Minimum Data Set] | | |
| 45867-9 | Number of days of training and skill practice in amputation or prosthesis care [Minimum Data Set] | | |
| 45868-7 | Number of days of training and skill practice in communication [Minimum Data Set] | | |
| 45869-5 | Number of days of other rehabilitation or restorative techniques or procedures [Minimum Data Set] | | |
| 45870-3 | Bed rails - full bed rails on all open sides of bed [Minimum Data Set] | | |
| 45871-1 | Bed rails - other types of side rails used [Minimum Data Set] | | |
| 45872-9 | Trunk restraint [Minimum Data Set] | | |
| 45873-7 | Limb restraint [Minimum Data Set] | | |
| 45874-5 | Chair prevents rising [Minimum Data Set] | | |
| 45875-2 | Number hospital admissions in last 90 days [Minimum Data Set] | | |
| 1-8 | | Acyclovir [Susceptibility] | |
| 10-9 | | Amdinocillin [Susceptibility] by Serum bactericidal titer | |
| 100-8 | | Cefoperazone [Susceptibility] by Minimum inhibitory concentration (MIC) | |
| 1000-9 | | DBG Ab [Presence] in Serum or Plasma from Blood product unit | |
| 10000-8 | | R wave duration in lead AVR | |
| 10001-6 | | R wave duration in lead I | |
| 100018-1 | | Hospice care Note | |
| 100019-9 | | ALK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
| 10002-4 | | R wave duration in lead II | |
| 100020-7 | | GNA11 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
| 100021-5 | | GNAQ gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
| 100022-3 | | IDH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
| 100023-1 | | IDH2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
| 100024-9 | | SETBP1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
| 100025-6 | | SRSF2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
| 100026-4 | | MET gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
| 100027-2 | | SMAD4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
| 100028-0 | | FBXW7 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
| 100029-8 | | Cancer related multigene analysis in Plasma cell-free DNA by Molecular genetics method | |
| 10003-2 | | R wave duration in lead III | |
| 100034-8 | | Provider of automated external defibrillator use | |
| 100035-5 | | Exam finding location of Chest | |
| 100036-3 | | Exam finding location of Lung | |
| 100037-1 | | Patient contact disposition EMS unit | |
| 100038-9 | | Patient evaluation disposition EMS unit | |
| 100039-7 | | Crew disposition for patient care EMS unit | |
| 10004-0 | | R wave duration in lead V1 | |
| 100040-5 | | Patient transport disposition EMS unit | |
| 100041-3 | | Aminoglycoside [Susceptibility] | |
| 100042-1 | | Atovaquone [Susceptibility] | |
| 100043-9 | | Azithromycin+Ethambutol [Susceptibility] | |
| 100044-7 | | Cefcapene [Susceptibility] | |
| 100045-4 | | Cefozopran [Susceptibility] | |
| 100046-2 | | Cefquinome [Susceptibility] | |
| 100047-0 | | Cefteram [Susceptibility] | |
| 100048-8 | | Clarithromycin+Ethambutol [Susceptibility] | |
| 100049-6 | | Eravacycline [Susceptibility] | |
| 10005-7 | | R wave duration in lead V2 | |
| 100050-4 | | Erythromycin+Ethambutol [Susceptibility] | |
| 100051-2 | | Ethambutol+rifAMPin [Susceptibility] | |
| 100052-0 | | Flomoxef [Susceptibility] | |
| 100053-8 | | Fluoroquinolone [Susceptibility] | |
| 100054-6 | | Gamithromycin [Susceptibility] | |
| 100055-3 | | Optochin [Susceptibility] | |
| 100056-1 | | Panipenem [Susceptibility] | |
| 100057-9 | | Prothionamide [Susceptibility] | |
| 100058-7 | | Prulifloxacin [Susceptibility] | |
| 100059-5 | | Rifapentine [Susceptibility] | |
| 10006-5 | | R wave duration in lead V3 | |
| 100060-3 | | Tildipirosin [Susceptibility] | |
| 100061-1 | | Tosufloxacin [Susceptibility] | |
| 100062-9 | | Standard Dermatology Outcome Measures panel | |
| 100063-7 | | Primary skin concern | |
| 100064-5 | | Itch severity Reporting Period - Reported | |
| 100065-2 | | Satisfied with treatment | |
| 100066-0 | | Specular microscopy panel | |
| 100067-8 | | Eye Image magnification | |
| 100068-6 | | Right eye Fixation point [Angle] | |
| 100069-4 | | Left eye Fixation point [Angle] | |
| 10007-3 | | R wave duration in lead V4 | |
| 100070-2 | | Right cornea Cell density | |
| 100071-0 | | Left cornea Cell density | |
| 100072-8 | | Right cornea Coefficient of variation | |
| 100073-6 | | Left cornea Coefficient of variation | |
| 100074-4 | | Right cornea Hexagonality | |
| 100075-1 | | Left cornea Hexagonality | |
| 100076-9 | | Right cornea Endothelial cells counted | |
| 100077-7 | | Left cornea Endothelial cells counted | |
| 100078-5 | | Right cornea Endothelial cell area.min | |
| 100079-3 | | Left cornea Endothelial cell area.min | |
| 10008-1 | | R wave duration in lead V5 | |
| 100080-1 | | Right cornea Endothelial cell area.max | |
| 100081-9 | | Left cornea Endothelial cell area.max | |
| 100082-7 | | Right cornea Endothelial cell area.mean | |
| 100083-5 | | Left cornea Endothelial cell area.mean | |
| 100084-3 | | Right cornea Cell area.standard deviation | |
| 100085-0 | | Left cornea Cell area.standard deviation | |
| 100086-8 | | Right cornea Type of Analysis method by Specular microscopy | |
| 100087-6 | | Toxocara canis 24-35kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100088-4 | | Taenia solium larva Ab bands panel - Serum by Immunoblot | |
| 100089-2 | | Taenia solium larva 6-8kD Ab [Presence] in Serum by Immunoblot | |
| 10009-9 | | R wave duration in lead V6 | |
| 100090-0 | | Taenia solium larva 45kD Ab [Presence] in Serum by Immunoblot | |
| 100091-8 | | Trypanosoma cruzi Ab [Units/volume] in Serum by Immunoassay | |
| 100092-6 | | Trypanosoma cruzi Ab bands panel - Serum by Immunoblot | |
| 100093-4 | | Trypanosoma cruzi 15-16kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100094-2 | | Trypanosoma cruzi 21-22kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100095-9 | | Trypanosoma cruzi 27-28kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100096-7 | | Trypanosoma cruzi 42kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100097-5 | | Trypanosoma cruzi 45-47kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100098-3 | | Trypanosoma cruzi 120-200kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100099-1 | | Trypanosoma cruzi 160kD IgG Ab [Presence] in Serum by Immunoblot | |
| 1001-7 | | DBG Ab [Presence] in Serum or Plasma from Donor | |
| 10010-7 | | R' wave amplitude in lead AVF | |
| 100100-7 | | Fasciola sp IgG Ab [Presence] in Serum by Immunoassay | |
| 100101-5 | | Fasciola sp 8-9kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100102-3 | | Fasciola sp 27-28kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100103-1 | | Fasciola sp 60kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100104-9 | | Fasciola sp 42kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100105-6 | | Filaria IgG and IgM panel - Serum | |
| 100106-4 | | Filaria IgG Ab [Presence] in Serum by Immunoassay | |
| 100107-2 | | Leishmania sp IgG Ab [Presence] in Serum by Immunoassay | |
| 100108-0 | | Leishmania sp IgG Ab [Units/volume] in Serum by Immunoassay | |
| 100109-8 | | Leishmania sp Ab bands panel - Serum by Immunoblot | |
| 10011-5 | | R' wave amplitude in lead AVL | |
| 100110-6 | | Leishmania sp 14kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100111-4 | | Leishmania sp 16kD IgG Ab [Presence] in Serum by Immunoblot | |
| 100112-2 | | Fasciola sp Ab bands panel - Serum by Immunoblot | |
| 100113-0 | | Helicobacter pylori Ab panel - Serum | |
| 100114-8 | | Toxoplasma gondii 30kD Ab [Presence] in Serum by Immunoblot | |
| 100115-5 | | Toxoplasma gondii 31kD Ab [Presence] in Serum by Immunoblot | |
| 100116-3 | | Toxoplasma gondii 33kD Ab [Presence] in Serum by Immunoblot | |
| 100117-1 | | Toxoplasma gondii 40kD Ab [Presence] in Serum by Immunoblot | |
| 100118-9 | | Toxoplasma gondii 41kD Ab [Presence] in Serum by Immunoblot | |
| 100119-7 | | Toxoplasma gondii 45kD Ab [Presence] in Serum by Immunoblot | |
| 10012-3 | | R' wave amplitude in lead AVR | |
| 100120-5 | | Chlamydia trachomatis Ab panel - Serum | |
| 100121-3 | | Chlamydia trachomatis IgA Ab [Presence] in Serum by Immunoassay | |
| 100122-1 | | Chlamydophila pneumoniae Ab panel - Serum | |
| 100123-9 | | Chlamydophila pneumoniae IgA Ab [Presence] in Serum by Immunoassay | |
| 100124-7 | | Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum by Immunoassay | |
| 100125-4 | | Chlamydophila psittaci Ab panel - Serum | |
| 100126-2 | | Bordetella pertussis Ab.IgG panel - Serum | |
| 100127-0 | | Campylobacter sp Ab panel - Serum | |
| 100128-8 | | Cryptococcus sp Ag panel - Serum | |
| 100129-6 | | Schistosoma sp Ab [Titer] in Serum by Hemagglutination | |
| 10013-1 | | R' wave amplitude in lead I | |
| 100130-4 | | Schistosoma mansoni Ab [Presence] in Serum by Immunoblot | |
| 100131-2 | | Schistosoma sp 8kD Ab [Presence] in Serum by Immunoblot | |
| 100132-0 | | Schistosoma sp 9kD Ab [Presence] in Serum by Immunoblot | |
| 100133-8 | | Schistosoma sp 10kD Ab [Presence] in Serum by Immunoblot | |
| 100134-6 | | Schistosoma sp 11kD Ab [Presence] in Serum by Immunoblot | |
| 100135-3 | | Schistosoma sp 12-13kD Ab [Presence] in Serum by Immunoblot | |
| 100136-1 | | Schistosoma sp 14-15kD Ab [Presence] in Serum by Immunoblot | |
| 100137-9 | | Schistosoma sp 15-16kD Ab [Presence] in Serum by Immunoblot | |
| 100138-7 | | Schistosoma sp 18-19kD Ab [Presence] in Serum by Immunoblot | |
| 100139-5 | | Schistosoma sp 22-24kD Ab [Presence] in Serum by Immunoblot | |
| 10014-9 | | R' wave amplitude in lead II | |
| 100140-3 | | Schistosoma sp 30-34kD Ab [Presence] in Serum by Immunoblot | |
| 100141-1 | | Schistosoma sp 65kD Ab [Presence] in Serum by Immunoblot | |
| 100142-9 | | Schistosoma sp 70kD Ab [Presence] in Serum by Immunoblot | |
| 100143-7 | | Schistosoma sp 80kD Ab [Presence] in Serum by Immunoblot | |
| 100144-5 | | Schistosoma sp 95kD Ab [Presence] in Serum by Immunoblot | |
| 100145-2 | | Schistosoma sp 110kD Ab [Presence] in Serum by Immunoblot | |
| 100146-0 | | Schistosoma sp 120kD Ab [Presence] in Serum by Immunoblot | |
| 100147-8 | | Toxoplasma gondii Ab bands panel - Serum by Immunoblot | |
| 100148-6 | | Schistosoma sp Ab bands panel - Serum by Immunoblot | |
| 100149-4 | | 6-oxo-piperidine-2-carboxylate and 6(R+S)-oxo-propylpiperidine-2-carboxylate panel - Urine and Serum or Plasma | |
| 10015-6 | | R' wave amplitude in lead III | |
| 100150-2 | | 6(R+S)-oxo-propylpiperidine-2-carboxylate [Moles/volume] in Plasma | |
| 100151-0 | | 6-oxo-piperidine-2-carboxylate [Moles/volume] in Plasma | |
| 100152-8 | | 6-oxo-piperidine-2-carboxylate/Creatinine [Molar ratio] in Urine | |
| 100153-6 | | 6(R+S)-oxo-propylpiperidine-2-carboxylate/Creatinine [Molar ratio] in Urine | |
| 100154-4 | | Specimen collection supervision level | |
| 100155-1 | | Left cornea Type of Analysis method by Specular microscopy | |
| 100156-9 | | SARS-CoV-2 (COVID-19) variant [Type] in Specimen by NAA with probe detection | |
| 100157-7 | | SARS-CoV-2 (COVID-19) lineage [Type] in Specimen by Sequencing | |
| 10016-4 | | R' wave amplitude in lead V1 | |
| 10017-2 | | R' wave amplitude in lead V2 | |
| 10018-0 | | R' wave amplitude in lead V3 | |
| 10019-8 | | R' wave amplitude in lead V4 | |
| 1002-5 | | DBG Ab [Presence] in Serum or Plasma | |
| 10020-6 | | R' wave amplitude in lead V5 | |
| 10021-4 | | R' wave amplitude in lead V6 | |
| 10022-2 | | R' wave duration in lead AVF | |
| 10023-0 | | R' wave duration in lead AVL | |
| 10024-8 | | R' wave duration in lead AVR | |
| 10025-5 | | R' wave duration in lead I | |
| 10026-3 | | R' wave duration in lead II | |
| 10027-1 | | R' wave duration in lead III | |
| 10028-9 | | R' wave duration in lead V1 | |
| 10029-7 | | R' wave duration in lead V2 | |
| 1003-3 | | Indirect antiglobulin test.complement specific reagent [Presence] in Serum or Plasma | |
| 10030-5 | | R' wave duration in lead V3 | |
| 10031-3 | | R' wave duration in lead V4 | |
| 10032-1 | | R' wave duration in lead V5 | |
| 10033-9 | | R' wave duration in lead V6 | |
| 10034-7 | | S wave amplitude in lead AVF | |
| 10035-4 | | S wave amplitude in lead AVL | |
| 10036-2 | | S wave amplitude in lead AVR | |
| 10037-0 | | S wave amplitude in lead I | |
| 10038-8 | | S wave amplitude in lead II | |
| 10039-6 | | S wave amplitude in lead III | |
| 1004-1 | | Direct antiglobulin test.complement specific reagent [Presence] on Red Blood Cells | |
| 10040-4 | | S wave amplitude in lead V1 | |
| 10041-2 | | S wave amplitude in lead V2 | |
| 10042-0 | | S wave amplitude in lead V3 | |
| 10043-8 | | S wave amplitude in lead V4 | |
| 10044-6 | | S wave amplitude in lead V5 | |
| 10045-3 | | S wave amplitude in lead V6 | |
| 10046-1 | | S wave duration in lead AVF | |
| 10047-9 | | S wave duration in lead AVL | |
| 10048-7 | | S wave duration in lead AVR | |
| 10049-5 | | S wave duration in lead I | |
| 1005-8 | | Indirect antiglobulin test.IgG specific reagent [Presence] in Serum or Plasma | |
| 10050-3 | | S wave duration in lead II | |
| 10051-1 | | S wave duration in lead III | |
| 10052-9 | | S wave duration in lead V1 | |
| 10053-7 | | S wave duration in lead V2 | |
| 10054-5 | | S wave duration in lead V3 | |
| 10055-2 | | S wave duration in lead V4 | |
| 10056-0 | | S wave duration in lead V5 | |
| 10057-8 | | S wave duration in lead V6 | |
| 10058-6 | | S' wave amplitude in lead AVF | |
| 10059-4 | | S' wave amplitude in lead AVL | |
| 1006-6 | | Direct antiglobulin test.IgG specific reagent [Interpretation] on Red Blood Cells | |
| 10060-2 | | S' wave amplitude in lead AVR | |
| 10061-0 | | S' wave amplitude in lead I | |
| 10062-8 | | S' wave amplitude in lead II | |
| 10063-6 | | S' wave amplitude in lead III | |
| 10064-4 | | S' wave amplitude in lead V1 | |
| 10065-1 | | S' wave amplitude in lead V2 | |
| 10066-9 | | S' wave amplitude in lead V3 | |
| 10067-7 | | S' wave amplitude in lead V4 | |
| 10068-5 | | S' wave amplitude in lead V5 | |
| 10069-3 | | S' wave amplitude in lead V6 | |
| 1007-4 | | Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells | |
| 10070-1 | | S' wave duration in lead AVF | |
| 10071-9 | | S' wave duration in lead AVL | |
| 10072-7 | | S' wave duration in lead AVR | |
| 10073-5 | | S' wave duration in lead I | |
| 10074-3 | | S' wave duration in lead II | |
| 10075-0 | | S' wave duration in lead III | |
| 10076-8 | | S' wave duration in lead V1 | |
| 10077-6 | | S' wave duration in lead V2 | |
| 10078-4 | | S' wave duration in lead V3 | |
| 10079-2 | | S' wave duration in lead V4 | |
| 1008-2 | | Indirect antiglobulin test.polyspecific reagent [Presence] in Serum or Plasma | |
| 10080-0 | | S' wave duration in lead V5 | |
| 10081-8 | | S' wave duration in lead V6 | |
| 10082-6 | | ST initial amplitude 6 ms in lead AVF | |
| 10083-4 | | ST initial amplitude 6 ms in lead AVL | |
| 10084-2 | | ST initial amplitude 6 ms in lead AVR | |
| 10085-9 | | ST initial amplitude 6 ms in lead I | |
| 10086-7 | | ST initial amplitude 6 ms in lead II | |
| 10087-5 | | ST initial amplitude 6 ms in lead III | |
| 10088-3 | | ST initial amplitude 6 ms in lead V1 | |
| 10089-1 | | ST initial amplitude 6 ms in lead V2 | |
| 1009-0 | | Deprecated Direct antiglobulin test.poly specific reagent [Presence] on Red Blood Cells | |
| 10090-9 | | ST initial amplitude 6 ms in lead V3 | |
| 10091-7 | | ST initial amplitude 6 ms in lead V4 | |
| 10092-5 | | ST initial amplitude 6 ms in lead V5 | |
| 10093-3 | | ST initial amplitude 6 ms in lead V6 | |
| 10094-1 | | ST slope in lead AVF | |
| 10095-8 | | ST slope in lead AVL | |
| 10096-6 | | ST slope in lead AVR | |
| 10097-4 | | ST slope in lead I | |
| 10098-2 | | ST slope in lead II | |
| 10099-0 | | ST slope in lead III | |
| 101-6 | | Cefoperazone [Susceptibility] by Disk diffusion (KB) | |
| 1010-8 | | E sup(w) Ab [Presence] in Serum or Plasma from Blood product unit | |
| 10100-6 | | ST slope in lead V1 | |
| 10101-4 | | ST slope in lead V2 | |
| 10102-2 | | ST slope in lead V3 | |
| 10103-0 | | ST slope in lead V4 | |
| 10104-8 | | ST slope in lead V5 | |
| 10105-5 | | ST slope in lead V6 | |
| 10106-3 | | ST wave end displacement in lead AVF | |
| 10107-1 | | ST wave end displacement in lead AVL | |
| 10108-9 | | ST wave end displacement in lead AVR | |
| 10109-7 | | ST wave end displacement in lead I | |
| 1011-6 | | E sup(w) Ab [Presence] in Serum or Plasma from Donor | |
| 10110-5 | | ST wave end displacement in lead II | |
| 10111-3 | | ST wave end displacement in lead III | |
| 10112-1 | | ST wave end displacement in lead V1 | |
| 10113-9 | | ST wave end displacement in lead V2 | |
| 10114-7 | | ST wave end displacement in lead V3 | |
| 10115-4 | | ST wave end displacement in lead V4 | |
| 10116-2 | | ST wave end displacement in lead V5 | |
| 10117-0 | | ST wave end displacement in lead V6 | |
| 10118-8 | | ST wave mid displacement in lead AVF | |
| 10119-6 | | ST wave mid displacement in lead AVL | |
| 1012-4 | | E sup(w) Ab [Presence] in Serum or Plasma | |
| 10120-4 | | ST wave mid displacement in lead AVR | |
| 10121-2 | | ST wave mid displacement in lead I | |
| 10122-0 | | ST wave mid displacement in lead II | |
| 10123-8 | | ST wave mid displacement in lead III | |
| 10124-6 | | ST wave mid displacement in lead V1 | |
| 10125-3 | | ST wave mid displacement in lead V2 | |
| 10126-1 | | ST wave mid displacement in lead V3 | |
| 10127-9 | | ST wave mid displacement in lead V4 | |
| 10128-7 | | ST wave mid displacement in lead V5 | |
| 10129-5 | | ST wave mid displacement in lead V6 | |
| 1013-2 | | E sup(w) Ag [Presence] on Red Blood Cells from Blood product unit | |
| 10130-3 | | T' wave amplitude in lead AVF | |
| 10131-1 | | T' wave amplitude in lead AVL | |
| 10132-9 | | T' wave amplitude in lead AVR | |
| 10133-7 | | T' wave amplitude in lead I | |
| 10134-5 | | T' wave amplitude in lead II | |
| 10135-2 | | T' wave amplitude in lead III | |
| 10136-0 | | T' wave amplitude in lead V1 | |
| 10137-8 | | T' wave amplitude in lead V2 | |
| 10138-6 | | T' wave amplitude in lead V3 | |
| 10139-4 | | T' wave amplitude in lead V4 | |
| 1014-0 | | E sup(w) Ag [Presence] on Red Blood Cells from Donor | |
| 10140-2 | | T' wave amplitude in lead V5 | |
| 10141-0 | | T' wave amplitude in lead V6 | |
| 10142-8 | | T wave amplitude in lead AVF | |
| 10143-6 | | T wave amplitude in lead AVL | |
| 10144-4 | | T wave amplitude in lead AVR | |
| 10145-1 | | T wave amplitude in lead I | |
| 10146-9 | | T wave amplitude in lead II | |
| 10147-7 | | T wave amplitude in lead III | |
| 10148-5 | | T wave amplitude in lead V1 | |
| 10149-3 | | T wave amplitude in lead V2 | |
| 1015-7 | | E sup(w) Ag [Presence] on Red Blood Cells | |
| 10150-1 | | T wave amplitude in lead V3 | |
| 10151-9 | | T wave amplitude in lead V4 | |
| 10152-7 | | T wave amplitude in lead V5 | |
| 10153-5 | | T wave amplitude in lead V6 | |
| 10154-3 | | Chief complaint Narrative - Reported | |
| 10155-0 | | History of allergies, reported | |
| 10156-8 | | History of Childhood diseases Narrative | |
| 10157-6 | | History of family member diseases Narrative | |
| 10158-4 | | History of Functional status Narrative | |
| 10159-2 | | History of Industrial exposure Narrative | |
| 1016-5 | | E Ab [Presence] in Serum or Plasma from Blood product unit | |
| 10160-0 | | History of Medication use Narrative | |
| 10161-8 | | History of Occupational exposure Narrative | |
| 10162-6 | | History of pregnancies Narrative | |
| 10163-4 | | History of pregnancies | |
| 10164-2 | | History of Present illness Narrative | |
| 10165-9 | | Deprecated History of psychiatric symptoms and diseases Narrative | |
| 10166-7 | | History of Social function Narrative | |
| 10167-5 | | History of Surgical procedures Narrative | |
| 10168-3 | | History of Cardiovascular system disorders Narrative | |
| 10169-1 | | History of Ear disorders Narrative | |
| 1017-3 | | E Ab [Presence] in Serum or Plasma from Donor | |
| 10170-9 | | History of Endocrine system disorders Narrative | |
| 10171-7 | | History of Eyes disorders Narrative | |
| 10172-5 | | History of Hematologic system disorders Narrative | |
| 10173-3 | | History of Musculoskeletal system disorders Narrative | |
| 10174-1 | | History of Nose disorders Narrative | |
| 10175-8 | | History of Oral cavity disorders Narrative | |
| 10176-6 | | History of Reproductive system disorders Narrative | |
| 10177-4 | | History of Respiratory system disorders Narrative | |
| 10178-2 | | History of Skin disorders Narrative | |
| 10179-0 | | History of Throat and Neck disorders Narrative | |
| 1018-1 | | E Ab [Presence] in Serum or Plasma | |
| 10180-8 | | History of Throat and Neck disorders | |
| 10181-6 | | History of Urinary tract disorders Narrative | |
| 10182-4 | | History of Travel Narrative | |
| 10183-2 | | Hospital discharge medications Narrative | |
| 10184-0 | | Hospital discharge physical findings Narrative | |
| 10185-7 | | Hospital discharge procedures Narrative | |
| 10186-5 | | Identifying information Narrative Observed | |
| 10187-3 | | Review of systems Narrative - Reported | |
| 10188-1 | | Review of systems overview Narrative - Reported | |
| 10189-9 | | Review of systems overview - Reported | |
| 1019-9 | | E Ag [Presence] on Red Blood Cells from Blood product unit | |
| 10190-7 | | Mental status Narrative | |
| 10191-5 | | Physical findings of Abdomen Narrative | |
| 10192-3 | | Physical findings of Back Narrative | |
| 10193-1 | | Physical findings of Breasts Narrative | |
| 10194-9 | | Physical findings of Neurologic deep tendon reflexes Narrative | |
| 10195-6 | | Physical findings of Ear Narrative | |
| 10196-4 | | Physical findings of Extremities Narrative | |
| 10197-2 | | Physical findings of Eye Narrative | |
| 10198-0 | | Physical findings of Genitourinary tract Narrative | |
| 10199-8 | | Physical findings of Head Narrative | |
| 102-4 | | Cefoperazone [Susceptibility] by Serum bactericidal titer | |
| 1020-7 | | E Ag [Presence] on Red Blood Cells from Donor | |
| 10200-4 | | Physical findings of Heart Narrative | |
| 10201-2 | | Physical findings of Mouth and Throat and Teeth Narrative | |
| 10202-0 | | Physical findings of Nervous system Narrative | |
| 10203-8 | | Physical findings of Nose Narrative | |
| 10204-6 | | Physical findings of Pelvis Narrative | |
| 10205-3 | | Physical findings of Rectum Narrative | |
| 10206-1 | | Physical findings of Skin Narrative | |
| 10207-9 | | Physical findings of Thorax and Lungs Narrative | |
| 10208-7 | | Physical findings of Vessels Narrative | |
| 10209-5 | | Physical findings of Neurologic balance and Coordination Narrative | |
| 1021-5 | | E Ag [Presence] on Red Blood Cells | |
| 10210-3 | | Physical findings of General status Narrative | |
| 10211-1 | | Physical findings of Sense of touch Narrative | |
| 10212-9 | | Physical findings of Strength Narrative | |
| 10213-7 | | Surgical operation note anesthesia Narrative | |
| 10214-5 | | Surgical operation note anesthesia duration | |
| 10215-2 | | Surgical operation note findings Narrative | |
| 10216-0 | | Surgical operation note fluids Narrative | |
| 10217-8 | | Surgical operation note indications [Interpretation] Narrative | |
| 10218-6 | | Surgical operation note postoperative diagnosis Narrative | |
| 10219-4 | | Surgical operation note preoperative diagnosis Narrative | |
| 1022-3 | | Fy sup(a) Ab [Presence] in Serum or Plasma from Blood product unit | |
| 10220-2 | | Surgical operation note prep time duration | |
| 10221-0 | | Surgical operation note specimens taken Narrative | |
| 10222-8 | | Surgical operation note surgical complications [Interpretation] Narrative | |
| 10223-6 | | Surgical operation note surgical procedure Narrative | |
| 10224-4 | | Hemodynamic method special circumstances | |
| 10225-1 | | Cardiac measurement device Institution inventory number | |
| 10226-9 | | Oxygen content in Intravascular space | |
| 10227-7 | | Cardiac measurement device Vendor model number | |
| 10228-5 | | Cardiac measurement device Vendor serial number | |
| 10229-3 | | Hemodynamic method Type of | |
| 1023-1 | | Fy sup(a) Ab [Presence] in Serum or Plasma from Donor | |
| 10230-1 | | Left ventricular Ejection fraction | |
| 10231-9 | | Right ventricular Ejection fraction | |
| 10232-7 | | Oxygen content in Aorta root | |
| 10233-5 | | Oxygen content in Left atrium | |
| 10234-3 | | Oxygen content in Right atrium | |
| 10235-0 | | Oxygen content in High right atrium | |
| 10236-8 | | Oxygen content in Low right atrium | |
| 10237-6 | | Oxygen content in Mid right atrium | |
| 10238-4 | | Oxygen content in Left ventricle | |
| 10239-2 | | Oxygen content in Right ventricular outflow tract | |
| 1024-9 | | Fy sup(a) Ab [Presence] in Serum or Plasma | |
| 10240-0 | | Oxygen content in Right ventricle | |
| 10241-8 | | Oxygen content in Coronary sinus | |
| 10242-6 | | Oxygen content in Ductus arteriosus | |
| 10243-4 | | Oxygen content in Inferior vena cava | |
| 10244-2 | | Oxygen content in Left pulmonary artery | |
| 10245-9 | | Oxygen content in Main pulmonary artery | |
| 10246-7 | | Oxygen content in Right pulmonary artery | |
| 10247-5 | | Oxygen content in Pulmonary wedge | |
| 10248-3 | | Oxygen content in Superior vena cava | |
| 10249-1 | | Heart rate device Institution inventory number | |
| 1025-6 | | Fy sup(a) Ag [Presence] on Red Blood Cells from Blood product unit | |
| 10250-9 | | Heart rate device Vendor model number | |
| 10251-7 | | Heart rate device Vendor serial number | |
| 10252-5 | | Biliary drain site | |
| 10253-3 | | Type of Biliary drain | |
| 10254-1 | | Type of Peritoneal drain | |
| 10255-8 | | Type of Subarachnoid drain | |
| 10256-6 | | Biliary drain Institution inventory number | |
| 10257-4 | | Chest tube Institution inventory number | |
| 10258-2 | | Enteral tube Institution inventory number | |
| 10259-0 | | Gastrostomy tube Institution inventory number | |
| 1026-4 | | Fy sup(a) Ag [Presence] on Red Blood Cells from Donor | |
| 10260-8 | | GI tube Institution inventory number | |
| 10261-6 | | Intravascular tube Institution inventory number | |
| 10262-4 | | IO tube Institution inventory number | |
| 10263-2 | | Nasogastric tube Institution inventory number | |
| 10264-0 | | Oral tube Institution inventory number | |
| 10265-7 | | Peritoneal drain Institution inventory number | |
| 10266-5 | | Peritoneal tube Institution inventory number | |
| 10267-3 | | Rate control device Institution inventory number | |
| 10268-1 | | Stool collection device Institution inventory number | |
| 10269-9 | | Subarachnoid drain Institution inventory number | |
| 1027-2 | | Fy sup(a) Ag [Presence] on Red Blood Cells | |
| 10270-7 | | Synovial drain Institution inventory number | |
| 10271-5 | | Tube or drain Institution inventory number | |
| 10272-3 | | Upper GI tube Institution inventory number | |
| 10273-1 | | Bladder irrigation tube Institution inventory number | |
| 10274-9 | | Urine tube Institution inventory number | |
| 10275-6 | | Wound drain device Institution inventory number | |
| 10276-4 | | Peritoneal drain site | |
| 10277-2 | | Stool collection site | |
| 10278-0 | | Subarachnoid drain site | |
| 10279-8 | | Biliary drain Vendor model number | |
| 1028-0 | | Fy sup(b) Ab [Presence] in Serum or Plasma from Blood product unit | |
| 10280-6 | | Chest tube Vendor model number | |
| 10281-4 | | Enteral tube Vendor model number | |
| 10282-2 | | Gastrostomy tube Vendor model number | |
| 10283-0 | | GI tube Vendor model number | |
| 10284-8 | | Intravascular tube Vendor model number | |
| 10285-5 | | IO tube Vendor model number | |
| 10286-3 | | Nasogastric tube Vendor model number | |
| 10287-1 | | Oral tube Vendor model number | |
| 10288-9 | | Peritoneal drain Vendor model number | |
| 10289-7 | | Peritoneal tube Vendor model number | |
| 1029-8 | | Fy sup(b) Ab [Presence] in Serum or Plasma from Donor | |
| 10290-5 | | Rate control device Vendor model number | |
| 10291-3 | | Stool collection device Vendor model number | |
| 10292-1 | | Subarachnoid drain Vendor model number | |
| 10293-9 | | Synovial drain Vendor model number | |
| 10294-7 | | Tube or drain Vendor model number | |
| 10295-4 | | Upper GI tube Vendor model number | |
| 10296-2 | | Bladder irrigation tube Vendor model number | |
| 10297-0 | | Urine tube Vendor model number | |
| 10298-8 | | Wound drain device Vendor model number | |
| 10299-6 | | Biliary drain Vendor serial number | |
| 103-2 | | Ceforanide [Susceptibility] by Minimum lethal concentration (MLC) | |
| 1030-6 | | Fy sup(b) Ab [Presence] in Serum or Plasma | |
| 10300-2 | | Chest tube Vendor serial number | |
| 10301-0 | | Enteral tube Vendor serial number | |
| 10302-8 | | Gastrostomy tube Vendor serial number | |
| 10303-6 | | GI tube Vendor serial number | |
| 10304-4 | | Intravascular tube Vendor serial number | |
| 10305-1 | | IO tube Vendor serial number | |
| 10306-9 | | Nasogastric tube Vendor serial number | |
| 10307-7 | | Oral tube Vendor serial number | |
| 10308-5 | | Peritoneal drain Vendor serial number | |
| 10309-3 | | Peritoneal tube Vendor serial number | |
| 1031-4 | | Fy sup(b) Ag [Presence] on Red Blood Cells from Blood product unit | |
| 10310-1 | | Rate control device Vendor serial number | |
| 10311-9 | | Stool collection device Vendor serial number | |
| 10312-7 | | Subarachnoid drain Vendor serial number | |
| 10313-5 | | Synovial drain Vendor serial number | |
| 10314-3 | | Tube or drain Vendor serial number | |
| 10315-0 | | Upper GI tube Vendor serial number | |
| 10316-8 | | Bladder irrigation tube Vendor serial number | |
| 10317-6 | | Urine tube Vendor serial number | |
| 10318-4 | | Wound drain device Vendor serial number | |
| 10319-2 | | Enema device Institution inventory number | |
| 1032-2 | | Fy sup(b) Ag [Presence] on Red Blood Cells from Donor | |
| 10320-0 | | Enema device Vendor model number | |
| 10321-8 | | Enema device Vendor serial number | |
| 10322-6 | | Potassium intake 24 hour | |
| 10323-4 | | Wound drain fluid [Appearance] Lower GI tract | |
| 10324-2 | | Breath rate device Institution inventory number | |
| 10325-9 | | Breath rate device Vendor model number | |
| 10326-7 | | Breath rate device Vendor serial number | |
| 10327-5 | | Eosinophils/100 leukocytes in Sputum by Manual count | |
| 10328-3 | | Lymphocytes/100 leukocytes in Cerebral spinal fluid by Manual count | |
| 10329-1 | | Monocytes/100 leukocytes in Cerebral spinal fluid by Manual count | |
| 1033-0 | | Fy sup(b) Ag [Presence] on Red Blood Cells | |
| 10330-9 | | Monocytes/100 leukocytes in Body fluid by Manual count | |
| 10331-7 | | Rh [Type] in Blood | |
| 10332-5 | | Cortisol [Mass/volume] in Serum or Plasma --pre 250 ug corticotropin IM | |
| 10333-3 | | Appearance of Cerebral spinal fluid | |
| 10334-1 | | Cancer Ag 125 [Units/volume] in Serum or Plasma | |
| 10335-8 | | Color of Cerebral spinal fluid | |
| 10336-6 | | Gonadotropin peptide [Mass/volume] in Urine | |
| 10337-4 | | Procollagen type I [Mass/volume] in Serum | |
| 10338-2 | | Barbiturates [Mass/volume] in Serum or Plasma | |
| 10339-0 | | FLUoxetine+Norfluoxetine [Mass/volume] in Serum or Plasma | |
| 1034-8 | | Fetal cell screen [Interpretation] in Blood | |
| 10340-8 | | Molindone [Mass/volume] in Serum or Plasma | |
| 10341-6 | | Norpropoxyphene [Mass/volume] in Serum or Plasma | |
| 10342-4 | | Sulfamethoxazole [Mass/volume] in Serum or Plasma | |
| 10343-2 | | Temazepam [Mass/volume] in Serum or Plasma | |
| 10344-0 | | Tranylcypromine [Mass/volume] in Serum or Plasma | |
| 10345-7 | | Trihexyphenidyl [Mass/volume] in Urine | |
| 10346-5 | | Hemoglobin A [Units/volume] in Blood by Electrophoresis | |
| 10347-3 | | Babesia microti identified in Blood by Light microscopy | |
| 10348-1 | | Bordetella parapertussis Ab [Presence] in Serum | |
| 10349-9 | | Brucella sp Ab [Units/volume] in Serum | |
| 1035-5 | | Fresh frozen plasma given [Volume] | |
| 10350-7 | | Herpes simplex virus IgM Ab [Titer] in Serum by Immunoassay | |
| 10351-5 | | HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification | |
| 10352-3 | | Bacteria identified in Genital specimen by Aerobe culture | |
| 10353-1 | | Bacteria identified in Nose by Aerobe culture | |
| 10354-9 | | Bacteria identified in Urethra by Culture | |
| 10355-6 | | Microscopic observation [Identifier] in Bone marrow by Wright Giemsa stain | |
| 10356-4 | | Deprecated Microscopic observation [Identifier] in Stool by Trichrome stain | |
| 10357-2 | | Microscopic observation [Identifier] in Wound by Gram stain | |
| 10358-0 | | Teichoate Ab [Titer] in Serum by Immune diffusion (ID) | |
| 10359-8 | | Asialoganglioside GM1 IgM Ab [Titer] in Serum | |
| 1036-3 | | G Ab [Presence] in Serum or Plasma from Blood product unit | |
| 10360-6 | | DNA single strand IgG Ab [Units/volume] in Serum | |
| 10361-4 | | DNA single strand IgM Ab [Units/volume] in Serum | |
| 10362-2 | | Endomysium IgA Ab [Presence] in Serum | |
| 10363-0 | | Barbiturates [Presence] in Specimen | |
| 10364-8 | | Cotinine [Mass/mass] in Hair | |
| 10365-5 | | Cotinine [Mass/volume] in Serum or Plasma | |
| 10366-3 | | Cotinine [Mass/volume] in Urine | |
| 10367-1 | | Ethanol [Mass/volume] in Gastric fluid | |
| 10368-9 | | Lead [Mass/volume] in Capillary blood | |
| 10369-7 | | Opiates [Mass/mass] in Hair | |
| 1037-1 | | G Ab [Presence] in Serum or Plasma from Donor | |
| 10370-5 | | Phencyclidine [Mass/mass] in Hair | |
| 10371-3 | | Bite cells [Presence] in Blood by Light microscopy | |
| 10372-1 | | Blister cells [Presence] in Blood by Light microscopy | |
| 10373-9 | | Fragments [Presence] in Blood by Light microscopy | |
| 10374-7 | | Helmet cells [Presence] in Blood by Light microscopy | |
| 10375-4 | | Irregularly contracted cells [Presence] in Blood by Light microscopy | |
| 10376-2 | | Oval macrocytes [Presence] in Blood by Light microscopy | |
| 10377-0 | | Pencil cells [Presence] in Blood by Light microscopy | |
| 10378-8 | | Polychromasia [Presence] in Blood by Light microscopy | |
| 10379-6 | | Erythrocytes.dual population [Presence] in Blood by Light microscopy | |
| 1038-9 | | G Ab [Presence] in Serum or Plasma | |
| 10380-4 | | Stomatocytes [Presence] in Blood by Light microscopy | |
| 10381-2 | | Target cells [Presence] in Blood by Light microscopy | |
| 10382-0 | | Deprecated A,B variant NOS Ag [Presence] on Red Blood Cells from Blood product unit | |
| 10383-8 | | Deprecated A,B variant NOS Ag [Presence] on Red Blood Cells from Donor | |
| 10384-6 | | Deprecated A,B variant NOS Ag [Presence] on Red Blood Cells | |
| 10385-3 | | Albumin concentration given | |
| 10386-1 | | Albumin given [Volume] | |
| 10387-9 | | Autologous erythrocytes given [Volume] | |
| 10388-7 | | Autologous whole blood given [Volume] | |
| 10389-5 | | Blood product.other [Type] | |
| 1039-7 | | G Ag [Presence] on Red Blood Cells from Blood product unit | |
| 10390-3 | | Blood product special preparation [Type] | |
| 10391-1 | | Cytomegalovirus immune globulin given [Volume] | |
| 10392-9 | | Cryoprecipitate given [Volume] | |
| 10393-7 | | Factor IX given [Type] | |
| 10394-5 | | Factor IX given [Volume] | |
| 10395-2 | | Factor VIII given [Type] | |
| 10396-0 | | Factor VIII given [Volume] | |
| 10397-8 | | Hepatitis B immune globulin given [Volume] | |
| 10398-6 | | I Ag [Presence] on Red Blood Cells from Blood product unit | |
| 10399-4 | | I Ag [Presence] on Red Blood Cells from Donor | |
| 104-0 | | Ceforanide [Susceptibility] by Minimum inhibitory concentration (MIC) | |
| 1040-5 | | G Ag [Presence] on Red Blood Cells from Donor | |
| 10400-0 | | I Ag [Presence] on Red Blood Cells | |
| 10401-8 | | Immune serum globulin given [Type] | |
| 10402-6 | | Immune serum globulin given [Volume] | |
| 10403-4 | | Inject immune serum globulin [Volume] | |
| 10404-2 | | Inject Rh immune globulin [Volume] | |
| 10405-9 | | Inject varicella zoster virus immune globulin [Volume] | |
| 10406-7 | | little i Ag [Presence] on Red Blood Cells from Blood product unit | |
| 10407-5 | | little i Ag [Presence] on Red Blood Cells from Donor | |
| 10408-3 | | little i Ag [Presence] on Red Blood Cells | |
| 10409-1 | | Pentaspan given [Volume] | |
| 1041-3 | | G Ag [Presence] on Red Blood Cells | |
| 10410-9 | | Plasma given [Type] | |
| 10411-7 | | Plasma given [Volume] | |
| 10412-5 | | Platelets given [Type] | |
| 10413-3 | | Rh immune globulin given [Volume] | |
| 10414-1 | | Transfuse albumin [Volume] | |
| 10415-8 | | Transfuse blood exchange transfusion [Volume] | |
| 10416-6 | | Transfuse blood product other [Volume] | |
| 10417-4 | | Transfuse cryoprecipitate [Volume] | |
| 10418-2 | | Transfuse factor IX [Volume] | |
| 10419-0 | | Transfuse factor VIII [Volume] | |
| 1042-1 | | H Ab [Presence] in Serum or Plasma from Blood product unit | |
| 10420-8 | | Transfuse immune serum globulin [Volume] | |
| 10421-6 | | Transfuse Pentaspan [Volume] | |
| 10422-4 | | Transfuse plasma [Volume] | |
| 10423-2 | | Transfuse platelets [Volume] | |
| 10424-0 | | Transfuse erythrocytes [Volume] | |
| 10425-7 | | Transfuse Rh immune globulin [Volume] | |
| 10426-5 | | Transfuse whole blood [Volume] | |
| 10427-3 | | Transfuse whole blood autologous [Volume] | |
| 10428-1 | | Varicella zoster virus immune globulin given [Volume] | |
| 10429-9 | | AE 1 Ag [Presence] in Tissue by Immune stain | |
| 1043-9 | | H Ab [Presence] in Serum or Plasma from Donor | |
| 10430-7 | | AE 3 Ag [Presence] in Tissue by Immune stain | |
| 10431-5 | | B-cell Ag [Presence] in Tissue by Immune stain | |
| 10432-3 | | CD30 Ag [Presence] in Tissue by Immune stain | |
| 10433-1 | | BR-2 Ag [Presence] in Tissue by Immune stain | |
| 10434-9 | | Complement C3 Ag [Presence] in Tissue by Immune stain | |
| 10435-6 | | C5B-9 Ag [Presence] in Tissue by Immune stain | |
| 10436-4 | | CD15 Ag [Presence] in Tissue by Immune stain | |
| 10437-2 | | CD16 Ag [Presence] in Tissue by Immune stain | |
| 10438-0 | | CD20 Ag [Presence] in Tissue by Immune stain | |
| 10439-8 | | CD3 Ag [Presence] in Tissue by Immune stain | |
| 1044-7 | | H Ab [Presence] in Serum | |
| 10440-6 | | Deprecated CD30 Ag [Presence] in Tissue by Immune stain | |
| 10441-4 | | CD34 Ag [Presence] in Tissue by Immune stain | |
| 10442-2 | | CD56 Ag [Presence] in Tissue by Immune stain | |
| 10443-0 | | CD43 T-cell monocyte+myeloid cell Ag [Presence] in Tissue by Immune stain | |
| 10444-8 | | CD57 Ag [Presence] in Tissue by Immune stain | |
| 10445-5 | | CD11c Ag [Presence] in Tissue by Immune stain | |
| 10446-3 | | Leukocyte common Ag [Presence] in Tissue by Immune stain | |
| 10447-1 | | M-5 Ag [Presence] in Tissue by Immune stain | |
| 10448-9 | | T-cell Ag [Presence] in Tissue by Immune stain | |
| 10449-7 | | Glucose [Mass/volume] in Serum or Plasma --1 hour post meal | |
| 1045-4 | | Deprecated H NOS Ab [Presence] in Serum or Plasma from Blood product unit | |
| 10450-5 | | Glucose [Mass/volume] in Serum or Plasma --10 hours fasting | |
| 10451-3 | | Proinsulin [Moles/volume] in Serum or Plasma --12 hours fasting | |
| 10452-1 | | Xylose [Mass/volume] in Serum or Plasma --1 hour post 25 g xylose PO | |
| 10453-9 | | Xylose [Mass/volume] in Serum or Plasma --1 hour post dose xylose PO | |
| 10454-7 | | Xylose [Mass/volume] in Serum or Plasma --2 hours post 25 g xylose PO | |
| 10455-4 | | Xylose [Mass/volume] in Serum or Plasma --30 minutes post 25 g xylose PO | |
| 10456-2 | | Xylose [Mass/volume] in Serum or Plasma --6 hours fasting | |
| 10457-0 | | Actin Ag [Presence] in Tissue by Immune stain | |
| 10458-8 | | Alkaline phosphatase.placental Ag [Presence] in Tissue by Immune stain | |
| 10459-6 | | Alpha-1-Fetoprotein Ag [Presence] in Tissue by Immune stain | |
| 1046-2 | | Deprecated H NOS Ab [Presence] in Serum or Plasma from Donor | |
| 10460-4 | | Lactalbumin alpha Ag [Presence] in Tissue by Immune stain | |
| 10461-2 | | Alpha-1-Antichymotrypsin Ag [Presence] in Tissue by Immune stain | |
| 10462-0 | | Alpha 1 antitrypsin Ag [Presence] in Tissue by Immune stain | |
| 10463-8 | | Amyloid A component Ag [Presence] in Tissue by Immune stain | |
| 10464-6 | | Amyloid P component Ag [Presence] in Tissue by Immune stain | |
| 10465-3 | | Amyloid.prealbumin Ag [Presence] in Tissue by Immune stain | |
| 10466-1 | | Anion gap 3 in Serum or Plasma | |
| 10467-9 | | Beta-2-Microglobulin amyloid Ag [Presence] in Tissue by Immune stain | |
| 10468-7 | | Calcitonin Ag [Presence] in Tissue by Immune stain | |
| 10469-5 | | Carcinoembryonic Ag [Presence] in Tissue by Immune stain | |
| 1047-0 | | Deprecated H NOS Ab [Presence] in Serum or Plasma | |
| 10470-3 | | Choriogonadotropin Ag [Presence] in Tissue by Immune stain | |
| 10471-1 | | Chromogranin A Ag [Presence] in Tissue by Immune stain | |
| 10472-9 | | Chromogranin Ag [Presence] in Tissue by Immune stain | |
| 10473-7 | | Chymotrypsin Ag [Presence] in Tissue by Immune stain | |
| 10474-5 | | Collagen type 4 Ag [Presence] in Tissue by Immune stain | |
| 10475-2 | | Corticotropin Ag [Presence] in Tissue by Immune stain | |
| 10476-0 | | Desmin Ag [Presence] in Tissue by Immune stain | |
| 10477-8 | | Enolase.neuron specific Ag [Presence] in Tissue by Immune stain | |
| 10478-6 | | Eosinophil major basic protein Ag [Presence] in Tissue by Immune stain | |
| 10479-4 | | CD227 Ag [Presence] in Tissue by Immune stain | |
| 1048-8 | | Deprecated H NOS Ag [Presence] on Red Blood Cells from Blood product unit | |
| 10480-2 | | Estrogen+Progesterone receptor Ag [Presence] in Tissue by Immune stain | |
| 10481-0 | | Follitropin.alpha subunit Ag [Presence] in Tissue by Immune stain | |
| 10482-8 | | Follitropin.beta subunit Ag [Presence] in Tissue by Immune stain | |
| 10483-6 | | Gastrin Ag [Presence] in Tissue by Immune stain | |
| 10484-4 | | Glial fibrillary acidic protein Ag [Presence] in Tissue by Immune stain | |
| 10485-1 | | Glucagon Ag [Presence] in Tissue by Immune stain | |
| 10486-9 | | Hemoglobin Ag [Presence] in Tissue by Immune stain | |
| 10487-7 | | HMB-45 Ag [Presence] in Tissue by Immune stain | |
| 10488-5 | | IgA Ag [Presence] in Tissue by Immune stain | |
| 10489-3 | | IgA.heavy chain Ag [Presence] in Tissue by Immune stain | |
| 1049-6 | | Deprecated H NOS Ag [Presence] on Red Blood Cells from Donor | |
| 10490-1 | | IgE Ag [Presence] in Tissue by Immune stain | |
| 10491-9 | | IgG Ag [Presence] in Tissue by Immune stain | |
| 10492-7 | | IgG.heavy chain Ag [Presence] in Tissue by Immune stain | |
| 10493-5 | | IgM Ag [Presence] in Tissue by Immune stain | |
| 10494-3 | | IgM.heavy chain Ag [Presence] in Tissue by Immune stain | |
| 10495-0 | | Insulin Ag [Presence] in Tissue by Immune stain | |
| 10496-8 | | Kappa light chains Ag [Presence] in Tissue by Immune stain | |
| 10497-6 | | Immunoglobulin light chains.kappa amyloid Ag [Presence] in Tissue by Immune stain | |
| 10498-4 | | Keratin Ag [Presence] in Tissue by Immune stain | |
| 10499-2 | | Lambda light chains Ag [Presence] in Tissue by Immune stain | |
| 105-7 | | Ceforanide [Susceptibility] by Disk diffusion (KB) | |
| 1050-4 | | Deprecated H NOS Ag [Presence] on Red Blood Cells | |
| 10500-7 | | Immunoglobulin light chains.lambda amyloid Ag [Presence] in Tissue by Immune stain | |
| 10501-5 | | Lutropin [Units/volume] in Serum or Plasma | |
| 10502-3 | | Lutropin Ag [Presence] in Tissue by Immune stain | |
| 10503-1 | | Lysozyme Ag [Presence] in Tissue by Immune stain | |
| 10504-9 | | Myelin basic protein Ag [Presence] in Tissue by Immune stain | |
| 10505-6 | | Myoglobin Ag [Presence] in Tissue by Immune stain | |
| 10506-4 | | Peanut agglutinin Ag [Presence] in Tissue by Immune stain | |
| 10507-2 | | Prolactin Ag [Presence] in Tissue by Immune stain | |
| 10508-0 | | Prostate specific Ag [Presence] in Tissue by Immune stain | |
| 10509-8 | | Prostatic acid phosphatase Ag [Presence] in Tissue by Immune stain | |
| 1051-2 | | Hemolytic disease of newborn screen [Interpretation] in Blood | |
| 10510-6 | | S-100 Ag [Presence] in Tissue by Immune stain | |
| 10511-4 | | Serotonin Ag [Presence] in Tissue by Immune stain | |
| 10512-2 | | Somatostatin Ag [Presence] in Tissue by Immune stain | |
| 10513-0 | | Somatotropin Ag [Presence] in Tissue by Immune stain | |
| 10514-8 | | Synaptophysin Ag [Presence] in Tissue by Immune stain | |
| 10515-5 | | Thyroglobulin Ag [Presence] in Tissue by Immune stain | |
| 10516-3 | | Thyrotropin Ag [Presence] in Tissue by Immune stain | |
| 10517-1 | | Trypsin Ag [Presence] in Tissue by Immune stain | |
| 10518-9 | | Ulex europaeus I lectin Ag [Presence] in Tissue by Immune stain | |
| 10519-7 | | Vimentin Ag [Presence] in Tissue by Immune stain | |
| 1052-0 | | Deprecated I (intermediate) subtype [Presence] in Serum or Plasma from Blood product unit | |
| 10520-5 | | Coagulation factor VI Ag [Presence] in Tissue by Immune stain | |
| 10521-3 | | Coagulation factor VIII Ag [Presence] in Tissue by Immune stain | |
| 10522-1 | | Coagulation factor XIII Ag [Presence] in Tissue by Immune stain | |
| 10523-9 | | Fibrinogen Ag [Presence] in Tissue by Immune stain | |
| 10524-7 | | Microscopic observation [Identifier] in Cervix by Cyto stain | |
| 10525-4 | | Microscopic observation [Identifier] in Specimen by Cyto stain | |
| 10526-2 | | Microscopic observation [Identifier] in Sputum by Cyto stain | |
| 10527-0 | | Microscopic observation [Identifier] in Tissue by Cyto stain | |
| 10528-8 | | Acetophenazine [Mass/volume] in Serum or Plasma | |
| 10529-6 | | Amoxapine metabolite [Mass/volume] in Serum or Plasma | |
| 1053-8 | | Deprecated I (intermediate) subtype [Presence] in serum or plasma from donor | |
| 10530-4 | | Aprobarbital [Mass/volume] in Serum or Plasma | |
| 10531-2 | | Bretylium [Mass/volume] in Serum or Plasma | |
| 10532-0 | | Deprecated Desethylamiodarone [Mass/volume] in Serum or Plasma | |
| 10533-8 | | Propoxyphene+Acetaminophen [Mass/volume] in Serum or Plasma | |
| 10534-6 | | Diazoxide [Mass/volume] in Serum or Plasma | |
| 10535-3 | | Digoxin [Mass/volume] in Serum or Plasma | |
| 10536-1 | | Dipyridamole [Mass/volume] in Serum or Plasma | |
| 10537-9 | | Deprecated Doxepin+Nordoxepin [Mass/volume] in Serum or Plasma | |
| 10538-7 | | Deprecated Fluoxetine+Norfluoxetine [Mass/volume] in Serum or Plasma | |
| 10539-5 | | glipiZIDE [Mass/volume] in Serum or Plasma | |
| 1054-6 | | Deprecated I (intermediate) subtype [Presence] in srum | |
| 10540-3 | | glyBURIDE [Mass/volume] in Serum or Plasma | |
| 10541-1 | | Mepivacaine [Mass/volume] in Serum or Plasma | |
| 10542-9 | | Metharbital [Mass/volume] in Serum or Plasma | |
| 10543-7 | | Methsuximide+Normethsuximide [Mass/volume] in Serum or Plasma | |
| 10544-5 | | Normeperidine [Presence] in Serum or Plasma | |
| 10545-2 | | Normephenytoin [Mass/volume] in Serum or Plasma | |
| 10546-0 | | Normethsuximide [Mass/volume] in Serum or Plasma | |
| 10547-8 | | Primidone+PHENobarbital [Mass/volume] in Serum or Plasma | |
| 10548-6 | | Phenytoin Free/Phenytoin.total in Serum or Plasma | |
| 10549-4 | | Pirmenol [Mass/volume] in Serum or Plasma | |
| 1055-3 | | Deprecated I (intermediate) subtype [Presence] on Red Blood Cells from Blood product unit | |
| 10550-2 | | Deprecated Temazepam [Mass/volume] in Serum or Plasma | |
| 10551-0 | | Triamterene [Mass/volume] in Serum or Plasma | |
| 10552-8 | | Tricyclic antidepressants [Mass/volume] in Serum or Plasma | |
| 10553-6 | | Prostatic acid phosphatase [Enzymatic activity/volume] in Genital fluid | |
| 10554-4 | | Deprecated Prostatic acid phosphatase [Enzymatic activity/volume] in Seminal plasma | |
| 10555-1 | | Acrosin [Entitic Catalytic Activity] in Spermatozoa | |
| 10556-9 | | Deprecated Adenosine triphosphatase [Enzymatic activity/volume] in Seminal plasma | |
| 10557-7 | | Adenosine triphosphate [Moles/volume] in Semen | |
| 10558-5 | | Albumin [Moles/volume] in Semen | |
| 10559-3 | | Deprecated Calcium [Molecules/volume] in Semen | |
| 1056-1 | | Deprecated I (intermediate) subtype [Presence] on Red Blood Cells from donor | |
| 10560-1 | | Carcinoembryonic Ag [Units/volume] in Semen | |
| 10561-9 | | Carnitine [Moles/volume] in Semen | |
| 10562-7 | | Cells [#/volume] in Cervical mucus | |
| 10563-5 | | Cells other than spermatozoa [#/volume] in Semen | |
| 10564-3 | | Cervical mucus [Volume] | |
| 10565-0 | | Choriogonadotropin [Units/volume] in Semen | |
| 10566-8 | | Deprecated Choriogonadotropin [Molecules/volume] in Semen | |
| 10567-6 | | Citrate [Moles/volume] in Semen | |
| 10568-4 | | Clarity of Semen | |
| 10569-2 | | Color of Semen | |
| 1057-9 | | Deprecated I (intermediate) subtype [Presence] on Red Blood Cells | |
| 10570-0 | | Consistency of Cervical mucus | |
| 10571-8 | | Deprecated Consistency of Semen | |
| 10572-6 | | Deprecated Duration^post ejaculation | |
| 10573-4 | | Ferning [Type] in Cervical mucus | |
| 10574-2 | | Fructose [Moles/volume] in Semen | |
| 10575-9 | | Deprecated Gamma glutamyl transferase [Enzymatic activity/volume] in Semen | |
| 10576-7 | | Germ cells.immature [#/volume] in Semen | |
| 10577-5 | | Glucosidase [Enzymatic activity/volume] in Seminal plasma | |
| 10578-3 | | Glycerophosphocholine [Moles/volume] in Seminal plasma | |
| 10579-1 | | Leukocytes [#/volume] in Semen | |
| 1058-7 | | I Ab [Presence] in Serum or Plasma from Blood product unit | |
| 10580-9 | | Liquefaction [Time] in Semen | |
| 10581-7 | | Deprecated Number of entities [#] in Spermatozoa | |
| 10582-5 | | pH of Cervical mucus | |
| 10583-3 | | Prostaglandin F1 alpha [Moles/volume] in Semen | |
| 10584-1 | | Deprecated Protein [Mass/volume] in Semen | |
| 10585-8 | | Round cells [#/volume] in Semen | |
| 10586-6 | | Deprecated Volume of Semen | |
| 10587-4 | | Sexual abstinence duration | |
| 10588-2 | | Spermatogonia [#/volume] in Semen | |
| 10589-0 | | Spermatids [#/volume] in Semen by Streptoavidin-biotin method (SAB) | |
| 1059-5 | | I Ab [Presence] in Serum or Plasma from Donor | |
| 10590-8 | | Spermatids [#/volume] in Semen by Sertoli cell barrier method (SCB) | |
| 10591-6 | | Primary Spermatocytes [#/volume] in Semen | |
| 10592-4 | | Secondary Spermatocytes [#/volume] in Semen | |
| 10593-2 | | Spermatozoa Pyriform Head/100 spermatozoa in Semen | |
| 10594-0 | | Spermatozoa Tapering Head/100 spermatozoa in Semen | |
| 10595-7 | | Deprecated Spermatozoa [#/volume] in Semen | |
| 10596-5 | | Deprecated Spermatozoa Ab in cervical mucosa | |
| 10597-3 | | Deprecated Spermatozoa Ab in semen | |
| 10598-1 | | Deprecated Spermatozoa Ab in serum | |
| 10599-9 | | Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa by Kremer test | |
| 106-5 | | Ceforanide [Susceptibility] by Serum bactericidal titer | |
| 1060-3 | | I Ab [Presence] in Serum or Plasma | |
| 10600-5 | | Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa | |
| 10601-3 | | Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa --post coitus | |
| 10602-1 | | Spermatozoa Abnormal Head/100 spermatozoa in Semen | |
| 10603-9 | | Spermatozoa Abnormal Midpiece/100 spermatozoa in Semen | |
| 10604-7 | | Spermatozoa Abnormal Tail/100 spermatozoa in Semen | |
| 10605-4 | | Spermatozoa Agglutinated/100 spermatozoa in Semen | |
| 10606-2 | | Spermatozoa Amorphous Head/100 spermatozoa in Semen | |
| 10607-0 | | Spermatozoa Coiled Tail/100 spermatozoa in Semen | |
| 10608-8 | | Spermatozoa Cytoplasmic Droplet/100 spermatozoa in Semen | |
| 10609-6 | | Spermatozoa Duplicate Head/100 spermatozoa in Semen | |
| 1061-1 | | Deprecated I NOS Ab [Presence] in Serum or Plasma from Blood product unit | |
| 10610-4 | | Spermatozoa Duplicate Tail/100 spermatozoa in Semen | |
| 10611-2 | | Spermatozoa Immotile/100 spermatozoa in Semen | |
| 10612-0 | | Spermatozoa Large Oval Head/100 spermatozoa in Semen | |
| 10613-8 | | Spermatozoa Viable/100 spermatozoa in Semen | |
| 10614-6 | | Spermatozoa Motile w IgA/100 spermatozoa in Semen by Immunobead | |
| 10615-3 | | Spermatozoa Motile w IgA/100 spermatozoa in Semen by Mixed antiglobulin reaction | |
| 10616-1 | | Spermatozoa Motile w IgG/100 spermatozoa in Semen by Immunobead | |
| 10617-9 | | Spermatozoa Motile w IgG/100 spermatozoa in Semen by Mixed antiglobulin reaction | |
| 10618-7 | | Spermatozoa Motile w IgM/100 spermatozoa in Semen by Immunobead | |
| 10619-5 | | Spermatozoa Motile w IgM/100 spermatozoa in Semen by Mixed antiglobulin reaction | |
| 1062-9 | | Deprecated I NOS Ab [Presence] in Serum or Plasma from Donor | |
| 10620-3 | | Spermatozoa Nonprogressive/100 spermatozoa in Semen | |
| 10621-1 | | Spermatozoa Normal Head/100 spermatozoa in Semen | |
| 10622-9 | | Spermatozoa Normal/100 spermatozoa in Semen | |
| 10623-7 | | Spermatozoa Pin Head/100 spermatozoa in Semen | |
| 10624-5 | | Spermatozoa Rapid/100 spermatozoa in Semen | |
| 10625-2 | | Spermatozoa Round Head/100 spermatozoa in Semen | |
| 10626-0 | | Spermatozoa Slow/100 spermatozoa in Semen | |
| 10627-8 | | Spermatozoa Small Oval Head/100 spermatozoa in Semen | |
| 10628-6 | | Spermatozoa Tail Swelling/100 spermatozoa in Semen | |
| 10629-4 | | Spermatozoa Vacuolated Head/100 spermatozoa in Semen | |
| 1063-7 | | Deprecated I NOS Ab [Presence] in Serum or Plasma | |
| 10630-2 | | Spinnbarkeit [Length] in Cervical mucus | |
| 10631-0 | | Testosterone [Moles/volume] in Semen | |
| 10632-8 | | Time until next menstrual period | |
| 10633-6 | | Zinc [Moles/volume] in Semen | |
| 10634-4 | | Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma | |
| 10635-1 | | Acanthamoeba sp identified in Eye by Organism specific culture | |
| 10636-9 | | Acanthamoeba sp identified in Eye by Wet preparation | |
| 10637-7 | | Microscopic observation [Identifier] in Tissue by Night blue stain | |
| 10638-5 | | Thermophilic Actinomycetes colony count [#/volume] in Specimen by Organism specific culture | |
| 10639-3 | | Thermophilic Actinomycetes identified in Specimen by Organism specific culture | |
| 1064-5 | | Deprecated I NOS Ag [Presence] on Red Blood Cells from Blood product unit | |
| 10640-1 | | Deprecated Adenovirus 40+41 [Identifier] in Stool by Electron microscopy | |
| 10641-9 | | Amoeba identified in Aspirate by Immune stain | |
| 10642-7 | | Amoeba identified in Aspirate by Wet preparation | |
| 10643-5 | | Amoeba identified in Stool by Organism specific culture | |
| 10644-3 | | Arthropod identified in Specimen | |
| 10645-0 | | Aspergillus fumigatus Ag [Presence] in Tissue by Immunofluorescence | |
| 10646-8 | | Astrovirus [Identifier] in Stool by Electron microscopy | |
| 10647-6 | | Babesia sp identified in Blood by Thick film | |
| 10648-4 | | Babesia sp identified in Blood by Thin film | |
| 10649-2 | | Calicivirus [Identifier] in Stool by Electron microscopy | |
| 1065-2 | | Deprecated I NOS Ag [Presence] on Red Blood Cells from Donor | |
| 10650-0 | | Candida sp DNA [Presence] in Blood by Probe with amplification | |
| 10651-8 | | Chlamydophila pneumoniae Ag [Presence] in Sputum or Bronchial | |
| 10652-6 | | Chlamydophila pneumoniae DNA [Presence] in Sputum or Bronchial by Probe with amplification | |
| 10653-4 | | Clotrimazole [Susceptibility] by Minimum inhibitory concentration (MIC) | |
| 10654-2 | | Clotrimazole [Susceptibility] by Minimum lethal concentration (MLC) | |
| 10655-9 | | Coccidia identified in Duodenal fluid by Acid fast stain | |
| 10656-7 | | Coccidia identified in Stool by Acid fast stain | |
| 10657-5 | | Deprecated Cryptococcus neoformans Ag [Presence] in Tissue by Immunofluorescence | |
| 10658-3 | | Cyanobacterium identified in Water by Light microscopy | |
| 10659-1 | | Cyclospora sp identified in Stool by Acid fast stain | |
| 1066-0 | | Deprecated I NOS Ag [Presence] on Red Blood Cells | |
| 10660-9 | | Cytomegalovirus Ag [Presence] in Tissue by Immune stain | |
| 10661-7 | | Dinoflagellate identified in Water by Light microscopy | |
| 10662-5 | | Filaria identified in Blood by Concentration | |
| 10663-3 | | Filaria identified in Blood by Thick film | |
| 10664-1 | | Filaria identified in Blood by Thin film | |
| 10665-8 | | Fungus colony count [#/volume] in Specimen by Environmental culture | |
| 10666-6 | | Fungus identified in Tissue by Fontana-Masson stain | |
| 10667-4 | | Fungus identified in Specimen by Animal inoculation | |
| 10668-2 | | Fungus identified in Specimen by Environmental culture | |
| 10669-0 | | Fungus identified in Specimen by Sticky tape for environmental fungus | |
| 1067-8 | | Jk sup(a) Ab [Presence] in Serum or Plasma from Blood product unit | |
| 10670-8 | | Giardia lamblia [Presence] in Stool by Organism specific culture | |
| 10671-6 | | Helminth identified in Specimen | |
| 10672-4 | | Helminth+Arthropod identified in Specimen | |
| 10673-2 | | Hepatitis B virus core Ag [Presence] in Tissue by Immune stain | |
| 10674-0 | | Hepatitis B virus surface Ag [Presence] in Tissue by Immune stain | |
| 10675-7 | | Hepatitis B virus surface Ag [Presence] in Tissue by Orcein stain | |
| 10676-5 | | Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification | |
| 10677-3 | | Herpes simplex virus 1 Ag [Presence] in Tissue by Immune stain | |
| 10678-1 | | Herpes simplex virus 1+2 Ag [Presence] in Tissue by Immune stain | |
| 10679-9 | | Herpes simplex virus 2 Ag [Presence] in Tissue by Immune stain | |
| 1068-6 | | Jk sup(a) Ab [Presence] in Serum or Plasma from Donor | |
| 10680-7 | | Herpes simplex virus identified in Cerebral spinal fluid by Electron microscopy | |
| 10681-5 | | Herpes simplex virus identified in Tissue by Electron microscopy | |
| 10682-3 | | Deprecated HIV 1 RNA [Units/volume] in Serum or Plasma by Probe with amplification | |
| 10683-1 | | Hydatid cyst identified in Aspirate by Immune stain | |
| 10684-9 | | Hydatid cyst identified in Liver by Wet preparation | |
| 10685-6 | | Hydatid cyst identified in Lung tissue by Wet preparation | |
| 10686-4 | | Leishmania sp identified in Tissue by Giemsa stain | |
| 10687-2 | | Leishmania sp identified in Tissue by Organism specific culture | |
| 10688-0 | | Microscopic observation [Identifier] in Hair by KOH preparation | |
| 10689-8 | | Microscopic observation [Identifier] in Nail by KOH preparation | |
| 1069-4 | | Jk sup(a) Ab [Presence] in Serum or Plasma | |
| 10690-6 | | Microsporidia identified in Duodenal fluid by Trichrome stain modified | |
| 10691-4 | | Mushroom.toxic identified by Inspection | |
| 10692-2 | | Mushroom.toxic identified in Food by Light microscopy | |
| 10693-0 | | Mushroom.toxic identified in Vomitus by Light microscopy | |
| 10694-8 | | Naegleria sp identified in Tissue by Organism specific culture | |
| 10695-5 | | Naegleria sp identified in Tissue by Wet preparation | |
| 10696-3 | | Norovirus [Identifier] in Stool by Electron microscopy | |
| 10697-1 | | Nystatin [Susceptibility] by Minimum inhibitory concentration (MIC) | |
| 10698-9 | | Nystatin [Susceptibility] by Minimum lethal concentration (MLC) | |
| 10699-7 | | Onchocerca sp identified in Tissue by Wet preparation | |
| 107-3 | | Cefotaxime [Susceptibility] by Minimum lethal concentration (MLC) | |
| 1070-2 | | Jk sup(a) Ag [Presence] on Red Blood Cells from Blood product unit | |
| 10700-3 | | Orthopoxvirus [Identifier] in Skin by Electron microscopy | |
| 10701-1 | | Ova and parasites identified in Stool by Concentration | |
| 10702-9 | | Ova and parasites identified in Stool by Immune stain | |
| 10703-7 | | Ova and parasites identified in Stool by Kinyoun iron hematoxylin stain | |
| 10704-5 | | Ova and parasites identified in Stool by Light microscopy | |
| 10705-2 | | Human papilloma virus Ag [Presence] in Tissue by Immune stain | |
| 10706-0 | | Picornavirus [Identifier] in Stool by Electron microscopy | |
| 10707-8 | | Toxic Plant identified in Plant specimen by Inspection | |
| 10708-6 | | Toxic Plant identified in Vomitus by Light microscopy | |
| 10709-4 | | Plasmodium falciparum Ag [Units/volume] in Blood by Immunofluorescence | |
| 1071-0 | | Jk sup(a) Ag [Presence] on Red Blood Cells from Donor | |
| 10710-2 | | Plasmodium sp identified in Blood by Thin film | |
| 10711-0 | | Plasmodium vivax Ag [Units/volume] in Blood by Immunofluorescence | |
| 10712-8 | | Pneumocystis sp identified in Lung tissue | |
| 10713-6 | | Prototheca identified in Specimen by Culture | |
| 10714-4 | | Deprecated Rotavirus [Identifier] in Stool by Electron microscopy | |
| 10715-1 | | Schistosoma sp identified in Urine sediment by Light microscopy | |
| 10716-9 | | Schistosoma sp identified in Specimen by Organism specific culture | |
| 10717-7 | | Streptococcus pneumoniae Ab [Units/volume] in Serum by Latex agglutination | |
| 10718-5 | | Strongyloides sp Ab [Units/volume] in Serum by Immunoassay | |
| 10719-3 | | Taenia solium adult Ab [Units/volume] in Serum by Immunoblot | |
| 1072-8 | | Jk sup(a) Ag [Presence] on Red Blood Cells | |
| 10720-1 | | Terbinafine [Susceptibility] by Minimum inhibitory concentration (MIC) | |
| 10721-9 | | Terbinafine [Susceptibility] by Minimum lethal concentration (MLC) | |
| 10722-7 | | Torovirus [Identifier] in Stool by Electron microscopy | |
| 10723-5 | | Toxoplasma gondii IgA Ab [Units/volume] in Serum by Immunoassay | |
| 10724-3 | | Toxoplasma gondii IgE Ab [Units/volume] in Serum by Immunoassay | |
| 10725-0 | | Toxoplasma gondii DNA [Units/volume] in Body fluid by Probe with amplification | |
| 10726-8 | | Toxoplasma gondii [Presence] in Tissue by Giemsa stain | |
| 10727-6 | | Toxoplasma gondii identified in Tissue | |
| 10728-4 | | Trichomonas sp identified in Genital specimen by Organism specific culture | |
| 10729-2 | | Trypanosoma sp identified in Blood by Light microscopy | |
| 1073-6 | | Jk sup(b) Ab [Presence] in Serum or Plasma from Blood product unit | |
| 10730-0 | | Trypanosoma sp identified in Blood by Organism specific culture | |
| 10731-8 | | Trypanosoma sp identified in Blood by Thick film | |
| 10732-6 | | Trypanosoma sp identified in Blood by Thin film | |
| 10733-4 | | Trypanosoma sp identified in Blood by Wet preparation | |
| 10734-2 | | Varicella zoster virus identified in Skin by Electron microscopy | |
| 10735-9 | | Viral sequencing [Identifier] in Serum by Sequencing | |
| 10736-7 | | Virus identified in Cerebral spinal fluid by Electron microscopy | |
| 10737-5 | | Virus identified in Stool by Electron microscopy | |
| 10738-3 | | Virus identified in Tissue by Electron microscopy | |
| 10739-1 | | Virus identified in Specimen by Electron microscopy | |
| 1074-4 | | Jk sup(b) Ab [Presence] in Serum or Plasma from Donor | |
| 10740-9 | | Aluminum.microscopic observation [Identifier] in Bone by Histomorphometry stain | |
| 10741-7 | | Amyloid.microscopic observation [Identifier] in Brain by Thioflavine-S stain | |
| 10742-5 | | Amyloid.microscopic observation [Identifier] in Tissue by Bennhold stain.Putchler modified | |
| 10743-3 | | Amyloid.microscopic observation [Identifier] in Tissue by Highman stain | |
| 10744-1 | | Amyloid.microscopic observation [Identifier] in Tissue by Vassar-culling stain | |
| 10745-8 | | Bile.microscopic observation [Identifier] in Tissue by Fouchet stain | |
| 10746-6 | | Calcium.microscopic observation [Identifier] in Tissue by Von Kossa stain | |
| 10747-4 | | Collagen fibers+Elastic fibers.microscopic observation [Identifier] in Tissue by Lawson-Van Gieson stain | |
| 10748-2 | | Collagen fibers+Elastic fibers.microscopic observation [Identifier] in Tissue by Verhoeff-Van Gieson stain | |
| 10749-0 | | Collagen fibers.microscopic observation [Identifier] in Tissue by Van Gieson stain | |
| 1075-1 | | Jk sup(b) Ab [Presence] in Serum or Plasma | |
| 10750-8 | | Connective tissue.microscopic observation [Identifier] in Tissue by Trichrome stain.Masson | |
| 10751-6 | | Copper.microscopic observation [Identifier] in Tissue by Rhodamine stain | |
| 10752-4 | | Fat.microscopic observation [Identifier] in Milk by Sudan IV stain | |
| 10753-2 | | Fat.microscopic observation [Identifier] in Stool by Sudan IV stain | |
| 10754-0 | | Fat.microscopic observation [Identifier] in Tissue by Sudan IV stain | |
| 10755-7 | | Fungus.microscopic observation [Identifier] in Tissue by Methenamine silver stain.Grocott | |
| 10756-5 | | Glial fibers.microscopic observation [Identifier] in Tissue by Holzer stain | |
| 10757-3 | | Hematologic+Nuclear elements.microscopic observation [Identifier] in Tissue by Giemsa stain.May-Grunwald | |
jurisdiction[0]